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Many different kinds of the materials have been used as biomaterial in bone repair, bone 
disease healing and as replacement of damaged bone. These materials differ in characteristics 
such as composition, surface energy and surface roughness. On the other hand, they have all 
one common function, i.e. to provide a temporary or permanent support during the bone 
regeneration process. Therefore, a successful biomaterial should induce a fast and initially 
enhanced bone healing response and provide life long stability to the bone defect. Compared 
with other materials and methods, the use of calcium phosphate based compounds provides a 
more rapid fixation and stronger bonding with the host bone as well as increased uniform 
bone ingrowth and/or on-growth. 
1.1. Bone 
Bone is one of the most important biological structures [1]. Its major component is bone 
mineral, which is a nano-meter-sized, poorly crystalline calcium phosphate, called 
hydroxyapatite (HA). This HA has a highly hierarchical structure and is found in and along 
the collagen fibers [2-6]. Hydroxyapatite occurs in the form of complex microcrystals, which 
have a periodic repetition of the basic structural pattern of the constituent ions known as the 
unit cell. The unit cell has the formula Caio(P04)6(OH)2, which is a right rhombic prism 
when stacked and forms a hexagonal lattice as well as analogical structures [7-10]. However, 
the ideal stoichiometric crystalline hydroxyapatite with atomic Ca/P ratio of 1.67 is different 
from the composition of bone mineral, which may be represented by the following formula: 
Ca,,,-* (PO4) 5.x (HPO4, C03) x (OH, C03) 2.x 
The Ca/P ratio of bone mineral may vary from 1.50 to 1.90, depending on the age and bone 
site. The non-stoichiometry is primarily due to the presence of divalent ions, such as CO32" 
and HPO42', which are substituted for the trivalent PO43" ions, meanwhile Ca2tcould be 
substituted for Na+, K+, and Mg2+ [11-15]. Generally, the Ca/P ratio increases during aging of 
bone, suggesting that the amount of carbonate species increases for older bones. It is 
supposed that the Ca/P ratio in conjunction with nanocrystalline size and the poorly 
crystalline nature yields specific solubility property of the bone minerals. The solubility 
behavior of minerals is important in maintaining a delicate metabolic balance between these 
cells activities [16-20]. 
1.1.1. Bone disease, damage and healing 
Congenital, hereditary and other acquired diseases, such as achondroplasia, osteogenesis 
imperfecta (Brittle Bones, Fragilitas Ossium), osteopetrosis (Marble Bone Disease, 
Osteosclerosis), hereditary multiple exotosis (Osteochondromatosis) and enchondromatosis 
(Ollier's Disease), can result in bone damage. Also, unexpected events and traffic accidents 
can lead to bone damage and injury. In view of this, synthetic calcium phosphate materials 
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have been prepared and studied extensively in vitro and in vivo to repair bone or to be used as 
bone substitutes [21-23]. An ideal synthetic materials for bone repair should possess the 
following characteristics: (1) it should be biologically compatible, like hydroxyapatite or 
bone-like calcium phosphate based substances; (2) it should allow good fixation or structural 
integrity to keep the graft in place and intact until the bone healing process is completed; (3) 
it should be partly soluble to permit resorption during the bone remodeling phase; and, (4) the 
surface composition and morphology should mimic natural bone and the preparation method 
should be simple, repeatable and at lower temperature to beneficial to allow the inclusion of 
biomolecules, such as bone growth stimulating proteins that can favor the differentiation and 
proliferation of bone-forming cells. 
1.2. Calcium phosphate materials 
Because their chemical composition and crystal structure are similar to the calcium phosphate 
as occurs in bone mineral, synthetic calcium phosphate compounds have widely been studied 
as biomaterials for orthopedic and oral applications [23-25]. There are a number of different 
calcium phosphates (Table 1 ). 
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1.2.1. Calcium phosphite (CaHP03M CPI): In this compound, phosphor is in the oxidation 
state Ρ (III), which is different from the other calcium phosphate materials as listed in Table 1, 
where phosphor is in the oxidation state Ρ (V). Phosphite is widely used as inorganic or 
organic compound, but is only rarely used as biomaterial even although it also can be used to 
prepare hydroxyapatite [26, 27]. 
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1.2.2. Calcium metaphosphate (Ca(P03)2, CMP): This compound is used as componet for 
bioglass and has recently been found biocompatible [28-30]. 
1.2.3. Monocalcium phosphate monohydrate: (MCPM; Ca (H2PO4) 2 H2O): This is the 
most acidic CaP compounds, which dissolves easily in water solution at almost all pH values. 
It can transform into calcium metaphosphate (Ca(P03)2) after losing water by heating. 
Although this kind of calcium phosphate is not biocompatible, it can be used as component in 
CaP based bone cements (CPC) [31-33]. 
1.2.4. Dicalcium phosphate: This includes CaHP04 (DCP) as well as dicalcium phosphate 
dihydrate CaHP04.2H20, (DCPD) and is one of the biocompatible and biodegradable CaP 
compounds [34]. DCP results normally from the recrystallization of DCPD and is the most 
stable CaP compound at low pH. The conversion is faster in water at higher temperature and 
acidity [35]. This kind of CaP compound is widely used as ingredients of CPCs, such as, 
Bone Source® and Calcibon®, and Biofill® [36]. The aqueous solution contains a cohesion 
promoter (e.g. soluble starch, hyaluronic acid) and a setting accelerator (e.g.: Na2HP04, 
K2HPO,,) [36-38]. 
1.2.5. Tetracalcium phosphate (TetCP; Ca^PO^O): It has been reported that this 
material is biocompatible when used as a bone substitute [39]. Mixing equimolar quantities of 
DCP and CaC03 and milling them to fine powder, TTCP can be obtained by a solid 
state-reaction at high temperatures (typically 1400°C)[40]. When TTCP is mixed with DCP 
or DCPA in solution, HA is gradually formed. This CaP compound is also widely used in 
CPCs [41-43]. 
1.2.6. Octocalcium phosphate (OCP; CagHjiPCM^.sl̂ O): This is an intermediate reaction 
product of the bone mineral because it is a precursor for HAp formation in vivo and hence 
can enhance bone healing [44, 45]. OCP can be prepared by hydrolysis of α-TCP, [46]. It can 
be used as coating on a metallic implant surface [45, 47] and as cement component [48]. 
1.2.7. Hydroxyapatite: (HA; CasiPC^JjOH): HA is the main inorganic bone mineral. It is a 
very biocompatible and bioactive CaP compound and is considered to be osteoconductive 
[49-52]. HA is the most stable CaP compound in neutral and basic aqueous solution. Several 
methods to prepare HAP crystals have been reported, including solid-state reactions, plasma 
techniques, crystal growth under hydrothermal conditions, layer hydrolysis of other calcium 
phosphate salts, and sol-gel crystallization. Essentially the synthesis of HAP crystals from 
supersaturated aqueous solutions is advantageous due to low cost and simplicity. For example, 
HA can be prepared by using Ca and Ρ containing compounds such as Ca2Cl, Ca (NO3) 2, 
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Ca2C03, CaO, Ca (OH) 2, CaSCX,, H3PO4, NH4H2PO4, Na Η2Ρθ4, Κ H2PO4, Na2HP04, etc 
[53-58] Usually synthetic HA contains anions (HCO , HPO4 ), and cations (Na+, K.+,), which 
make the apatite deviate from the stoichiometry of HAP [59, 60] There are mainly three 
kinds of HAs, including amorphous HA, precipitated HA and the high temperature form of a 
stoichiometric HA HA is widely used as coating, bone filler and bone cement [61-65] 
1.2.8. TCP: Tricalcium phosphate: TCP has depending on the temperature, three 
polymorphs, including α-TCP (a-Ca3(P04)2), ß-TCP (ß-Ca3(P04)2) and α-TCP 
(α -Ca3(P04)2) A -TCP exists only at a very high temperature (above 1450oC) 
Α-TCP, ß-TCP and α-TCP have exactly the same chemical composition but differ in 
crystallographic structure TCP can be easily prepared by chemical reaction between calcium 
salt and soluble phosphate salts [66, 67, 68] Α-TCP and ß-TCP can be obtained by sintering 
Usually ß-TCP is obtained by thermal heating above 650oC, but α-TCP needs a much higher 
temperature, 1 e 11250C [67, 69] It is also possible to prepare TCP by solid reaction, such as 
by mixture of MCP and CaCOi and subsequent calcination [70] B-TCP has extensively been 
used as a bone substitute, which is degradatale by osteoclastic activity [71] Α-TCP is widely 
used as the main component of CPC [72] 
1.2.9. Biphasic calcium phosphate (BCP) Composites with different ratios of HA/ß-TCP 
have been developed in order to control the resorbabihty of the material and at the same time 
to maintain its osteoconductive properties [73] This kind of CaP composites shows good 
biocompatibihty and osteoconductivity [74] It is obtained either by chemical reaction in 
solution or by calcining PHA (precipitated Hydroxylapatite) (with a molar ratio Ca Ρ between 
1 5-1 67) above =700C'C [75] BCP is more degradatale than HA and the degradation rate 
increases with an increase of the ß-TCP content It is extensively used as scaffold material in 
tissue engineering and as component of CPC [76, 77] 
1.2.10. Oxyapatite (OXA; CaioiPC^O) This is a highly reactive material, which 
undergoes at temperatures lower than 800oC, even under vacuum, a small rehydration to give 
rise to an oxy-hydroxy apatite, which is stable in air at ordinary temperatures It exists only 
under a vacuum (10 A to 10 6 torr) or in sufficiently water-free gases (He, N2), in the 
temperature range 850 1050oC [78] It can be prepared by the partial decomposition of HA 
OXA is poorly understood due to the difficulties of detecting this phase [79] 
1.2.11. Fluoroapatite (FA, CaioiPC^éF:) This is "HA", where F substitutes the OH Pure 
fluoroapatite (FA) is probably not suited as bone replacement material because it is too stable 
and seems not to give osteoconduction [81] When combined to composites with 
hydroxyapatite (HA), it can improve the stability of the HA composite [82] It can be 
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prepared through solid solution by a sol-gel method but also other methods can be applied 
[83, 84] 
1.2.12. Calcium pyrophosphate (DCPP, Ca2P207) Dicalcium pyrophosphate (DCPP), with 
a formula of Ca2P207, is one of the intermediate products of biological mineralization, while 
HA is usually considered as the end products of this process [85] Extracellular inorganic 
pyrophosphate is important for the regulation of the mineralization of bone, and in the 
pathogenesis of Chondrocalcinosis, an arthritic disease in which calcium pyrophosphate 
dihydrate crystals form in articular cartilage [86] Although many studies suggest that 
crystalline dicalcium pyrophosphate is biocompatible, it is very complex to understand the 
role of this CaP materials in the bone formation process, because it is not only involved in 
bone formation but it is also present at the bone disease site [87-90] Therefore, more research 
to DCPP has to be done, including the amorphous properties of DCPP in vitro and in vivo, 
and the process during which the amorphous DCPP changes into crystalline or other 
structures Usually DCPP can be obtained by calcining DCP (CaHPO.,) at 1000°C for 3 h by 
reaction in solution [91, 92] Recently, DCPP has been developed as bioceramic for 
biomedical applications [93-95] 
Generally, the term CaP materials is used to describe a number of different materials that vary 
in composition, crystallmity and method of manufacturing as discussed above Their 
properties are determined not only by their chemical composition, crystal structure but also 
by the process with which they are produced For instance, the Ca/P ratio of both CMP 
(Ca(P03)2) and MCP (Ca (fyPO^ H2O) is 1 5, but the former is biocompatible and the later 
not It is very important to provide detailed information whenever the term CaP is used 
1.3. Calcium phosphate coatings and techniques 
There are a lot of calcium phosphate compounds that can be used for the manufacturing of 
dental and orthopedic implants Unfortunately, calcium phosphate ceramics are brittle and 
fragile, which hampers their use as load-bearing implants To avoid this disadvantage, 
calcium phosphate ceramics are applied as coating on mechanical strong metallic substrates 
in order to obtain implants which possess the bioactivity and biocompatibihty of calcium 
phosphates as well as the strength of metals [96-98] 
There are various deposition techniques available to prepare calcium phosphate coatings 
Among them plasma-spray deposition is the most popular and applicable method, because of 
its many advantages, such as the potential of plasma-sprayed coatings to enhance the 
long-term stability of the bond between metallic implants and the surrounding bone structure, 
to promote superior bone apposition, and to reduce healing time [99-103] However, the bond 
between a plasma-sprayed HA coating and underlying metallic substrate is mainly due to a 
mechanical interlocking mechanism [104,105] Defects as cracking, flaking and scratching 
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that are often found in plasma-sprayed HA coatings might eventually lead to delamination of 
the coating. The delamination of the coating not only enhances the release of metal ions, but 
it can also lead to loosening of the implant [106-109]. Another disadvantage of plasma spray 
deposition is that the chemical composition and crystal structure of the deposited coatings is 
different compared with the original HA. For example, plasma spray deposited HA coatings 
contain impurities, such as ß-tricalcium, tetracalcium phosphates, and calcium oxide, which 
can result in a biological adverse reaction [110, 111]. To enhance the bond strength and some 
other properties, a number of other coating techniques have been developed to apply calcium 
phosphate coatings (See Table 21) [112]. Among these coating techniques is radio frequency 
(RF) magnetron sputtering the most promising to obtain dense, thin CaP films that are 
strongly coherent to metal. Furthermore, the substrate temperature of the RF magnetron 
sputtering system can be controlled so that even polymer substrates are not destroyed or 
degraded during the sputtering process [113]. Another advantage of this technique is that two 
or more different targets can be used at the same time during the sputtering process. In this 
way the coating composition can be further controlled. Generally, the properties of calcium 
phosphate coatings are determined not only by the starting materials, but also by the 
production method. For instance, magnetron sputtering generates a homogeneous CaP layer 
consisted of nano-meter grade particles (Figure 1), whereas a layer produced by plasma 
spraying consists of mixed amorphous and crystalline phases depending on the parameters 
used. Most CaP coatings, irrespective of the used coating technique, need post heat-treatment 
to improve the crystal structure and to get a more preferable morphological surface from the 
biocompatibility and bioactivity point of view. Such a post heat-treatment procedure is one of 







as-sputtcred HA coating heat-treated HA coating 
Figure 1 : AFM macrographs of the RF magnetron sputtering HA coatings 
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Table 2 Techniques applied to deposit CaP coatings 




























~5 mm High speed, stronger fixation 
to substrate, 
0.5-3μιη Uniform coating thickness on 
flat substrates; dense coating 
30-200μιη High deposition rates; low 
cost 
0.05-5μηι Coating with crystalline and 
amorphous; coating with 
dense and porous 







Inexpensive; coatings applied 
quickly; can coat complex 
substrates 
Can coat complex shapes; 
Low processing temperatures; 
relatively cheap as coatings 
are very thin 
Uniform coating thickness, 
rapid deposition rates; can 
coat complex substrates 
Low processing temperatures; 
can form bonelike apatite; can 
coat complex shapes, can 
incorporate growth factors 
Produces dense coatings 
ESD [135,136] 0.1-200μπι Inexpensive; coatings applied 
quickly; can control coating 
composition and morphology 
Impurity, mechanical bonding to 
substrate, uneven coating surface 
Line of sight technique; 
expensive time consuming; 
produces amorphous coatings 
Line of sight technique; high 
temperatures induce 
decomposition; rapid cooling 
produces amorphous coatings 
Line of sight technique 
Line of sight technique, 
expensive; produces amorphous 
coatings 
Requires high sintering 
temperatures; thermal expansion 
mismatch 
Some processes require 
controlled atmosphere 
processing; expensive raw 
materials 
Difficult to produce crack-free 
coatings; requires high sintering 
temperatures 
Time consuming; Requires 
replenishment and a constant of 
pH of simulated body fluid 
Cannot coat complex substrates; 
high temperature required; 
thermal expansion mismatch; 
elastic property differences; 
expensive; removal/interaction of 
encapsulation material 
Partial amorphous coating, 
replenishment and a constant of 
pH of solution 
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1.4. Heat treatment and coating properties 
Just deposited CaP coatings are almost always amorphous or contain amorphous phases 
Therefore, they need a post annealing treatment to obtain crystalhnity However, we have to 
notice that the temperature to induce crystallization differs for coatings deposited by different 
techniques At present the main post deposition heat-treatment methods, include 1 heating in 
air for long time [137, 138], 2 heating in inert gas for a long time, which is rarely reported 
[139], 3 heating with infrared for a short time [140], 4 heating in water steam at a lower 
temperature [141, 142], 5, heating with excimer laser equipment [143, 144] 
Although the required temperatures of the post deposition heat treatment are different for CaP 
coatings obtained by different techniques, the temperature is considered the key factor to 
affect the coating phase composition and crystallinity [145, 146] Besides, water vapor is also 
an important factor in the heat treatment procedure (See Table 3) [112] Crystallization of 
amorphous Ca-P coatings occurs only above a certain temperature However, heat treatment 
at a high temperature (e g above 600oC) reduces the adhesive strength of a coating to the 
substrate and can even result in the buckling of the coating at the surface Further, with 
increase of the heat treatment temperature, the purity of the HA phase in the coating 
decreases [138, 147] Therefore, a decrease in heat treatment temperature might benefit the 
physicochemical and mechanical properties of HA coatings as well as their in vivo biological 
behavior [148] As the calcium phosphate compounds are sensitive to heating and may 
transform into another structural form during the annealing (chemical composition and 
crystal structure changes), variations in CaP composition can lead to different 
dissolution/precipitation behavior, which may have an effect on the bone response [149] 
Consequently, post deposition heat-treatment is a very complex process In order to obtain 
the most preferable crystallinity, phase composition and surface morphology, different heat 
treatment methods should be applied on similar deposited coatings 
Table 3 Crystallinity of sputtered CaP coating after different heat treatments 
Heat treatment Crystallinity (%) 
Temperature (°C) Without water vapor With water vapor 
As-sputtered coatings 0 0 
350 0 2 5±0 5 
400 1 9±0 4 2 8±0 6 
450 2 0±10 68 0±2 0 
500 62 0±2 0 65 0±1 0 
600 67 0±2 0 68 0±2 0 
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1.5. Bioactivity and biocompatibility 
Bioactivity refers to the material reaction in the biological environment, including release, 
resorption, and exchange of ions between the materials surface and the surrounding 
biological fluid. Biocompatibility refers to the biochemical, biomechanica! and 
bio-physiological aspects of the tissue response, i.e. the lack of an adverse tissue response. In 
view of this point, calcium phosphates show a preferable tissue response in the biological 
environment [150,151]. 
1.5.1. Dissolution and re-precipitation 
The CaP coating surface is especially crucial for the fixation mechanism of an implant in 
bone, because it is in direct contact with the bone and body fluid after implantation [152, 153]. 
Consequently, partial dissolution of CaP coatings is essential to trigger bone growth, but 
exceedingly rapid dissolution leads to poor bone bonding and coating disintegration 
[154-156]. Therefore, it is important to optimally control the coating characteristics by 
varying the processing conditions. For example, the characteristics and properties of an HA 
coating can be changed resulting in different degrees of dissolution, which will affect the 
clinical performance. 
Dissolution and re-precipitation happens immediately when the implant comes in contact 
with the biological surroundings. It is generally supposed that an amorphous coating shows 
higher dissolution than a crystalline coating. Therefore, crystallinity is the dominant factor for 
the dissolution of the HA coating [157, 158], Other factors that affect the coating solubility 
include Ca/P ratio, phase composition, microstructure, porosity, surface morphology and 
roughness, thickness, and coating texture. Most of these variables are the result of the used 
processing parameters. A coating with a Ca/P ratio > 1.67 shows a low solubility in liquids 
with a pH between 6.8-7.4 and a precipitate is formed fast on the coating surface. This in 
contrast to coatings with a Ca/P ratio <1.67, which dissolve fast in a solution with a pH 
ranging from 6.8 to 7.4 [159]. Generally, the order of relative solubility of CaP compounds is 
as follows: 
ACP»DCP > TTCP > α -TCP > ß-TCP»HA; 
Where ACP is amorphous calcium phosphate, DCP is monetite (CaHPCM, TTCP is 
tetracalcium phosphate (Ca4P209), TCP is tricalcium phosphate (Cai(PO<i)2), and HA is 
hydroxyapatite (Caio(P04)6(OH)2) [160, 161]. This dissolution order is in a neutral pH 
solution and the order will change according the change of pH. Further, it has been reported 
that the dissolution increases with an increase in porosity, an increase in surface area, a 
decrease in particle size, and a decrease in crystallinity [162-164]. As heat-treatment is a 
factor that influences the crystallinity of a CaP coating, this will eventually affect the 
dissolution behavior of the coating [149]. Protein and amino acids in the solution also have 
influence on the dissolution of CaP coating, because they interfere with the mineralization 
18 
General introduction 
process [165, 166] For example, it has been suggested that some organic macromolecules 
such as amino acids and proteins have a high affinity for CaP surfaces They bind to the Ca 
and Ρ in the apatite crystal, which results in inhibition of the growth and formation of CaP 
[167-169] Finally, the ability of the osteoblast-hke cells to attach, migrate, proliferate, and 
differentiate and eventually form bone depends on the vanous characteristics of the CaP 
coating surface 
1.5.2. Bone response 
A successful fixation of an implant in bone should occur fast, has to be initially strong and 
has to provide lifelong stability In view of this, both orthopedic and dental implants have 
been provided with CaP coatings After implantation, the Ca and Ρ as present in the coating 
surface dissolve, resulting in an increased concentration of these ions in the 
microenvironment close to the implant This is followed by re-precipitation of Ca and Ρ and 
the formation of a bone-like mineral layer [170, 171] This bone-like mineral layer is 
supposed to promote the adhesion of extracellular matrix, providing a preferred substrate for 
cell attachment and differentiated function of resident osteoblasts or committed osteoblast 
precursors [172] This promotion of the differentiation and expression of osteogenic cells 
results in a faster bone formation on CaP surfaces than on Ti substrates [173] Due to the 
involvement of dissolution and precipitation phenomena, the crystallinity of a CaP coating 
plays a major role in the cascade of biological events [173, 174-176] 
Usually m vivo evaluation provides the basic information and is the standard in developing 
and designing new implant materials [177] Different animal models have been used in 
evaluating the implant materials, including rat, rabbit, dog, sheep, goat and pig [178-183] 
Transmission electron microscopy (TEM) showed that the bone-bonding behavior of calcium 
phosphate ceramics at the bone-implant interface was not determined by the 
calcium/phosphate molar ratio [184] Amorphous substances or needle-like microcrystals 
were observed on the surface of all ceramics already 2 weeks after implantation However, 
chemical or mechanical bonding between bone and ceramics was not observed On the other 
hand, Porter et al [185] revealed that the process of mineralization of bone is associated with 
the crystallinity of plasma-sprayed HA coatings Ultrastructural examination showed the 
formation of biological apatite crystallites only on non-heat-treated coatings within 3 hours of 
implantation in dog bone Further, it has been reported that the ultimate interfacial strength 
values of RF sputtered HA coatings are statistically greater than the mean ultimate interfacial 
strength for non-coated Ti implants after 3 weeks of implantation After 12 weeks of 
installation, these statistical differences in the mean ultimate interfacial strengths between 
CaP-coated and non-coated Ti implants disappeared Nevertheless, histomorphometric 
evaluation indicated still a greater percent bone contact length for the CaP-coated implants, In 
addition, the as-deposited amorphous coating showed the highest contact percentage [186] 
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Evidently, the coating crystallmity affects the dissolution and precipitation of the deposited 
films, and eventually influences the bone formation [187-189] The dissolution of the CaP 
coating is supposed to evoke solution mediated events, which affect circulating 
biocomponents, such as proteins [190], bone cells, organic matrix components, and 
precipitated as well as resorbed minerals [191] In addition, it has been suggested that once 
early bone bonding is achieved, the biodégradation of thin CaP coatings is not detrimental to 
bone-coating-implant fixation, and does not compromise the long term bone response to the 
implant surface [192] In view of this, we have to emphasize that thin film technologies offer 
clearly a viable alternative to plasma spraying for the deposition of CaP coatings on implants 
In summary, we can conclude that the biological response to CaP coatings is determined not 
only by the coating characteristics but also by the biological surroundings in which the coated 
device is placed This is a complex process, which has not been completely well understood 
yet 
1.6. Objective of the research 
Considering the tight relation between CaP material and bone response, we decided to use RF 
magnetron sputtering to deposit and modify CaP coatings The overall objective of our 
studies was to deposit CaP coatings, which varied significantly in composition and structural 
arrangement and to evaluate their physicochemical and biological properties Therefore, we 
hypothesized that CaP coatings with a CaP ratio of 1 0, like pyrophosphate, are the driving 
parameter in the formation of a bioactive carbonate apatite surface Considering the aim of 
the study the following experimental issues were addressed 
1 The deposition of RF magnetron sputtered coatings with different Ca/P ratio's with targets 
composed of calcium pyrophosphate and hydroxyapatite and the characterization of their 
physicochemical and dissolution behavior, 
2 The deposition of thin CaP coatings with preferential composition and morphological 
structure as induced by heat treatment at lower temperature by hot steam (under 140 °C to 
80oC) or at higher temperature (500-700cC) by infrared treatment, 
3 The deposition of thin CaP coatings by RF magnetron sputtering on polymers and the 
effect of a heat treatment procedure on the final coating crystallmity, 
4 The performance of m vitro cell culture and in vivo experimental animal studies in order 
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Introduction 
Calcium phosphate (Ca-P) materials have been used as bone substitute or bone graft in 
dentistry, orthopedic- and reconstructive surgery because of their good biocompatibility and 
osteointegrative properties [1]. However, due to their brittle nature, the use of bulk Ca-P 
ceramics is limited to unloaded situations. To solve this problem, it has been proposed to 
apply Ca-P bioceramics as thin coatings on metallic substrates, resulting in implants that have 
the excellent biocompatible properties of calcium phosphate as well as the advantageous 
mechanical properties of metal. At the moment, various techniques are available for the 
deposition of calcium phosphate on metal implants, e.g. hot pressing, plasma or flame 
spraying, ion-beam sputter deposition, frit enameling, electrophoretic deposition, and sol-gel 
deposition [2-9]. 
Previous work by our group investigated the use of radiofrequency (RF) magnetron sputter 
deposition as a method of applying thin adherent calcium phosphate coatings to titanium 
implants. The results showed that the deposited films had an excellent adhesiveness and a 
good biological response, both in vitro and in vivo [10-13]. 
Recently, a lot of attention has been paid to pyrophosphate ceramics. These pyrophosphates 
are used as artificial bone filler and can be useful in a clinical setting characterized by 
abnormal bone resorption. The results of an in vitro osteoblast cell culture and in vivo animal 
study demonstrated already that pyrophosphate is biocompatible with bone cells [14-19]. 
Further, synthetic pyrophosphate can inhibit osteoclastic bone resorption and therefore is 
used for the treatment of bone diseases, such as tumor hypercalcemia and osteoporosis [20-
21]. Besides as bone substitute, pyrophosphate ceramic can also be useful as coating on 
medical- and oral implants. 
Consequently, the objective of the present study was to characterize the physicochemical and 
dissolution behavior of calcium-pyrophosphate coatings obtained by RF magnetron 
sputtering. 
Materials and Methods 
Ca-P coating deposition 
For the experiments commercially pure titanium (cpTi) disc were provided with various Ca-P 
sputter coatings. The discs measured 1mm in thickness and had a diameter of 12 mm. All 
discs were A^Os-blasted on one side. The following coatings were prepared: 
1-Calcium pyrophosphate- coating with a thickness of 2 μηι (Pyro). 
2-Hydroxyapatite coating- coating with a thickness of 2 μιτι (HA). 
RF magnetron sputter coatings were made by using a commercially available RF sputter 
deposition system (Edwards ESM 100). The target materials were calcium pyrophosphate (ß-
Ca2P207) and hydroxylapatite (CasiPO^sOH) granules (diameter 0.5-1.0mm). The test 
specimens were mounted on a rotating and water-cooled substrate holder. The distance 
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between target and substrate was 80 mm Before sputtering the metal substrates were cleaned 
by etching for 10 mm with argon ions During deposition, the argon pressure was kept at 5 
xlO 3 mbar and the sputter power was 400W 
After deposition, half of the coated specimens were subjected to an additional infrared heat 
treatment (HT) for 30 sec at 300oC (Quad Ellipse Chamber, Model E4-10-P, Research Ine ) 
Thereafter, the crystallographic structure of the coatings was evaluated Depending on the 
results, the heat-treatment procedure was repeated on new specimens till a crystalline coating 
structure was obtained In each new heat-treatment cycle the temperature was increased with 
50oC 
Before and after annealing, coatings were charactenzed as follows 
The crystallographic structure of each film was determined by thin film X-ray 
diffraction (XRD) using a Philips Θ-2Θ diffractometer using a CuKa -radiation 
The infrared spectra of the films on the substrates were obtained by reflection Fourier 
transform infrared spectroscopy (FTIR)(Perkin-Elmer) 
The surface topology of the films was examined using scanning electron microscopy 
(SEM) using a Jeol JSM-35 
The elemental composition of the films was determined with an energy dispersive 
spectroscopy (EDS) Repetitive measurements at different locations on the coating 
surface were performed 
In vitro bioactivity assay 
All coated specimens were incubated in 4 ml Simulated Body Fluid buffer (SBF) with a pH 
of 7 2 at 370C for 4 weeks (Table 1) The experiment was performed in triplicate At time 
points, 1, 2, 3 and 4 weeks, the SBF buffer solution was refreshed For each sample, the Ca 
and Ρ concentration in the solutions was determined in triplicate, respectively by OCPC 
(ortho-cresolphthalein complexone) method and spectrophotometer (Vitatron) 
At the end of the experiment, coated samples were retrieved out of the SBF solution After 
rinsing in aqua and drying at room temperature, the specimens were characterized by using 
XRD, FTIR, SEM and EDS 




























Buffered with tns(hydroxymelhyl) aminomethane (50 mM), set at pH 7 2 with 1 ON hydrochloric acid (Li 
1993) 
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Results 
Coating characterization before and after heat treatment 
X-ray diffraction 
The XRD patterns of the as-sputtered coatings showed an amorphous structure with no clear 
peaks (Figure 1). Further, a clear difference was observed in temperature as required to obtain 
crystallization between HA and pyrophosphate coatings (Figure 1). Infrared heat-treatment at 
550oC changed the amorphous sputtered HA coatings into a crystalline apatite structure with 
reflections 002, 211, 112, 202, resp. 25.9°, 31.9°, 32.4° and 34.0° in 2-Theta, comparative 
with the XRD pattern of HA powder (JCPDS #09-0432). In contrast, the sputtered 
amorphous pyrophosphate coating required an annealing temperature of 650ÜC to alter into 
crystalline beta-calcium pyrophosphate structure with reflections lines 201, 202, 008 and 212, 
which correspond to peaks at 26.6°, 27.7°, 29.5° and 30.7° in 2-Theta (JCPDS#09-0346). 
Also, for the crystalline pyrophosphate coatings an additional reflection peak was seen at 
27.6° in 2-Theta corresponding to titanium oxide (TÌO2). This indicated oxidation of these 
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Figure 1: XRD patterns of sputtered calcium phosphate coatings. The major peaks have been marked: # = Pyro, 
* = HA. and Λ = substrate 
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Figure 2: IR spectra of magnetron sputtered caleium phosphate coatings. 
Fourier transform infrared spectroscopy 
FTIR measurements showed for all the amorphous coatings two clusters of bands from 900-
1150 and from 550-600 cm' attributed to the major absorption modes associated with the 
presence of phosphate (Figure 2). Heat treatment of the amorphous HA coatings resulted in 
the appearance of the hydroxyl band at 630 cm', characteristic for hydroxylapatite and the 
appearance of various P-0 bands at a wavelength of 587, 630, 965, 1009, 1083 cm' (Figure 
2). Heat treatment of the sputtered amorphous pyrophosphate coatings resulted in the 
appearance of various P-0 bonds at the wavelength around 1202, 1163,1125, 1095, 1081, 
993, 957, 644, 608, and 522 cm'1, which are characteristic for the beta-calcium 
pyrophosphate structure (Figure 2). 
Scanning electron microscopy 
SEM examination of the sputtered coatings showed an excellent coverage of the substrate 
surface. Heat treatment was found to have no evident effect on the HA as well as 
pyrophosphate coating morphology (Figure 7A, 7D, 7G, and 7J). 
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Energy dispersive spectroscopy 
EDS analysis revealed that Ca/P ratio of amorphous as well as crystalline HA- and Pyro 
coatings varied between respectively 1.9-2.0 and 0.76-0.8. 
Coating characterization after soaking in SBF 
In vitro bioactivity assay 
Figure 3 and 4 show the calcium and phosphate concentrations in the SBF buffer for the 
various coatings during the 4-week incubation period. 
Partial dissolution of the amorphous coatings was observed characterized by a sharp increase 
in Ca concentration in the SBF solution from 1 to 2 weeks of incubation. Thereafter, the Ca 
concentration remained about constant. A similar dissolution pattern was observed for the Ρ 
concentration. After 4 weeks of incubation, amorphous HA coatings showed only a 
significant higher release of Ρ as compared to the Pyro coatings (ANOVA and Tukey 
multiple comparison test, P<0.001). 
In contrast with the amorphous specimens, all heat-treated coatings appeared to induce a very 
limited decrease in Ca and an increase in Ρ in the SBF solution during the 4 weeks 
incubation. Further, we observed that the HA heat-treated coatings did not cause a significant 
higher release of Ca and Ρ in the SBF solution than the Pyro heat-treated coatings (ANOVA 
and Tukey multiple comparison test, P>0.05). 
X-ray diffraction 
The XRD evaluation confirmed that all types of Ha and Pyro coatings were still present after 
4 weeks of incubation in SBF. Further, for both types of amorphous sputter coatings the XRD 
pattern remained almost the same during the incubation (Figure 5A and 5C). Only for the HA 
coatings, dissolution of amorphous material resulted in the appearance of some minor 
crystalline peaks at 26° and 31-33° 2-Theta (Figure 5 A). Also, the XRD pattern of the heat-
treated HA coatings did not change during incubation (Figure 5B). On the other hand, for the 
Pyro heat-treated coatings a ß-TCP peak appeared at 3 Γ 2-Theta already 1 week after 
incubation in SBF( Figure 5D). 
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Figure 3: Calcium release of various magnetron sputtered Ca-P coatings in SBF at 37° C. 
Figure 4; Phosphate release of various magnetron sputtered Ca-P coatings in SBF at 37° C. 
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Figure 5a; The X-ray diffraction pattern of amorphous HA coating after 4 weeks incubation in SBF at 37° C. (* 
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Figure 5b:The X-ray diffraction pattern of heat-treated HA coating after 4 weeks incubation in SBF at 37° C. (* 
= HA peaks) 
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Figure 5c: The X-ray diffraction pattern of amorphous pyrophosphate coating after 4 weeks incubation in SBF 
at 37° C. (Λ = substrate peaks) 
Figure 5d:The X-ray diffraction pattern of amorphous HA coating after 4 weeks incubation in SBF at 37' C. (# 
= Pyro, * = HA, + = TCP, and Λ = substrate peaks) 
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Fourier transform infrared spectroscopy 
FTIR spectra confirmed the partial dissolution of both amorphous HA and Pyro coatings, 
which was characterized by the disappearance of PO-bonds around 700 cm'1 for amorphous 
HA coatings at 4 weeks of incubation and around 1000-1100 cm'1 for amorphous Pyro 
coatings at 3 weeks of incubation (Figure 6A and 6B). For the heat-treated HA and heat 
treated pyrophosphate coatings no significant changes were seen in the FTIR bands (Figure 
6C and 6D). 
Β 
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Figure 6c-d:lR spectra of heat-treated HA and pyrophosphate coatings after 4 weeks incubation in SBF at 37° C 
Scanning electron microscopy 
SEM evaluation revealed no clear changes in coating surface morphology during the 
incubation in SBF (Figure 7). Only, occasionally drying artefacts were observed as 
characterized by the appearance of cracks in the coated layer (Figure 7H). 
Energy dispersive spectroscopy 
EDS examination showed that the Ca/P ratio of the amorphous Pyro coatings increased 
during the 4 weeks of incubation, while the Ca/P ratio of the amorphous HA coatings 
decreased. The Ca/P ratio of the heat-treated pyrophosphate coatings showed a slight increase 
during incubation and the Ca/P ratio of the HA heat-treated coatings stayed the same (Table 
2). 
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Figure 7: SEM graphs of as-sputtered and heat-treated coatings and after incubation in SBF; A = HA coating, 
Β = HA coating 3 wk in SBF, C = HA coating 4 wk in SBF, D = HA HT, E = HA HT 3 wk in SBF, 
F = HA HT 4 wk in SBF, G = Pyro coating, H = Pyro coating 3 wk in SBF, I = Pyro coating 4 wk in 
SBF, J = Pyro HT, Κ = Pyro HT 3 wk in SBF, L = Pyro HT 4 wk in SBF. 
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The aim of this study was to investigate the applicability of RF magnetron sputter sputtering 
for the production of calcium pyrophosphate coatings on titanium substrates. The results 
demonstrated that it is possible to deposit a dense, adherent calcium pyrophosphate coating 
by choosing the appropriate deposition parameters. 
XRD analysis demonstrated that the as deposited CaP coatings had an amorphous structure. 
The post heat treatment induced the crystal growth within the coatings, resulting in a 
crystalline structure. Further for the pyrophosphate coatings, the post heat treatment resulted 
in an increase of thickness of the TÌO2 layer. This increase is not considered to be a 
disadvantage for the long-term bone response. It has already reported that the growth of the 
titanium oxide layer can even enhance the bonding to bone [22]. 
XRD revealed that different crystal phases could be obtained after heat treatment of the 
amorphous CaP coatings with IR-irradiation, depending on the temperature during heating. 
Heat treatment below 650° C did not result in crystallization of amorphous pyrophosphate 
coatings. Under these conditions only the amorphous HA coating transformed into a 
crystalline apatite structure. However, after heat treatment at temperature of 650° C, the 
amorphous pyrophosphate coating changed into a crystalline ß-Ca2P207 structure. The reason 
for this difference in crystallization behavior is not completely clear yet; we assume that the 
activation energy for the crystallization of apatite coatings is lower then for the 
pyrophosphate coatings. Unfortunately, at the moment no scientific data are available to 
confirm this theory. Nevertheless, our results confirmed again that IR-irradiation is an 
excellent method to crystallize thin amorphous calcium phosphate coating in a fast and 
reproducible way. 
SEM examination showed that all as-sputtered and heat-treated coatings had a homogeneous 
and dense structure. Additional EDS measurements proved that the Ca/P ratio of the 
magnetron sputtered coatings as used in this study was higher than the theoretical value for 
HA, i.e. 2.0 instead of 1.67. For the pyrophosphate coatings, the Ca/P ratio was found to be 
lower than theoretical value, i.e. 0.76 instead of 1.0. Concerning the high Ca/P ratio of the 
HA, several studies have been published where preferential sputtering of calcium was 
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observed, probably due to the possibility of the phosphorus ions being pumped away before 
they are deposited on the substrate [23]. Besides, surface effects during the sputtering process 
and sputtering power are also important parameters that can affect the final Ca/P ratio of 
sputtered coatings [24]. An explanation for the decrease in Ca/P ratio of the pyrophosphate is 
the structure of the pyrophosphate anion. It has been described that pyrophosphates have a 
great tendency to occur in polymorphic phases and to consist of two PO4 tetrahedral bridged 
by a mutual oxygen atom [25]. Consequently, we can assume that the possibility of 
pyrophosphate ions being pumped away during sputtering is very low, due to the complex 
structure as compared to the orthophosphate anion. Further, it has to be noticed that PO4 
reaches the substrate surface easier and is much more volatile than Ca ions [25]. 
In addition to structural changes, the solubility of the various types coatings was investigated 
during incubation in simulated body fluid. A partial dissolution of the amorphous HA and 
Pyro coatings was observed characterized by the disappearance of the PO-bonds around 700 
cm"' in the IR spectra. In contrast, all heat-treated sputter coatings were observed to be stable 
under the test conditions. No dissolution or precipitate deposition was seen. These results 
corroborate with earlier studies [26], in which it was also shown that as-deposited calcium 
phosphate coatings were amorphous and dissolved in SBF solution with the same ionic 
concentrations as human blood plasma, but without any organic additives. However, heat-
treated CaP coatings remained intact when immersed in SBF and showed no formation of a 
CaP precipitate. Only immersion of heat-treated specimens in SBF with increased ionic 
concentrations, so-called SBFX with χ > 1.4, resulted in the formation of a precipitate. 
The EDS measurements demonstrated that incubation of the amorphous coatings in SBF had 
an effect on the Ca/P ratio, i.e. pyrophosphate coatings surface showed an increase in Ca/P 
ratio from 0.76 to 1.24, while the Ca/P ratio of the HA coatings decreased from 1.98 to 1.15 
during incubation. This indicates again that a sputter coated amorphous Ca/P film easily 
dissolves and exchanges in SBF, resulting in a change in Ca/ Ρ ratio. This in contrast to heat-
treated coatings, which are stable and hardly change in Ca/P ratio. Evidently, the dissolution 
is determined by the crystallinity of the deposited coatings, which is also in agreement with 
earlier findings using the same medium [29] 
Conclusion 
Based on the results of this study, it can be concluded that magnetron sputtering can be 
successfully used to deposit pyrophosphate coatings on metal substrates. Homogeneous and 
dense coating morphologies were obtained. All the as-sputtered coatings were amorphous and 
after IR-irradiation the coatings altered into a crystalline phase. The activation energy for the 
crystallization of amorphous pyrophosphate coating is higher as compared to amorphous 
hydroxylapatite coating. The amorphous coatings were instable in the simulated body fluid 
and dissolved partially within 4 weeks of incubation. All heat-treated coatings appeared to be 
stable in simulated body fluid. These results suggest that magnetron sputtering of calcium 
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pyrophosphate coating is a promising method for deposition of a bioceramic coating. Of 
course, the final bone biocompatibility of these coatings has to be proven in follow-up cell 
culture and experimental animal studies. 
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Introduction 
In the biomedical field, coatings are frequently applied onto the surface of metallic dental and 
orthopedic implants in order to improve their biological performance. Because of its 
similarity to the inorganic component of bone and teeth, calcium phosphate (CaP) ceramics 
are considered as a suitable class of materials for use as such a surface coating [1]. Therefore, 
CaP coatings on metallic substrates have been developed, which are currently used in loaded 
situations, like total joint replacements and dental root implants. In this way the mechanical 
strength of titanium and the biocompatibility of CaP are combined [2]. 
As demonstrated in various publications, CaP coatings show a favorable bone response 
compared with non-coated titanium implants. At the moment, various techniques are 
available for the deposition of calcium phosphate on metal implants [3-11]. Over the past few 
years, we have made use of an RF magnetron sputter coating technique to produce thin 
adherent CaP coatings on implants. The results showed that the deposited films had a good 
biological response, both in vitro and in vivo. The osteogenic capacity of CaP was shown to 
be dependent on the physicochemical properties, such as the coating composition, coating 
crystal as well as molecular structure and coating crystallinity. [12-19]. However, the final 
bone response can also be influenced by the structural arrangement of calcium phosphate 
ceramics, and besides HA other calcium phosphate ceramics like dicalcium phosphate and 
pyrophosphate play a role in the mechanism for the formation of a carbonated-apatite deposit. 
The capacity of biomatenals to initiate the formation of a carbonated-apatite layer is 
indicative for their bioactivity [20-23]. 
In view of the above mentioned, previous studies in our laboratory demonstrated that the 
dissolution behavior in simulated body fluid (SBF) of RF magnetron sputtered dicalcium 
pyrophosphate (DCPP) coatings was similar as compared to HA coatings. Further, rat bone 
marrow stromal cells proliferated and differentiated only on crystalline magnetron sputtered 
DCPP as well as HA coatings, while crystalline HA coatings induced an earlier osteogenic 
effect than the crystalline DCPP coatings [24]. Despite there favorable results, it has to be 
noticed that the physicochemical evaluation of pyrophosphate coatings is not as well studied 
as those of calcium phosphate coatings. Especially, investigations of mixtures of both 
materials are scarce. 
Therefore, the objective of the present study was to characterize the physicochemical 
properties of dicalcium pyrophosphate and hydroxylapatite coatings obtained by RF 
magnetron sputtering. 
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Materials and Methods 
Ca-P coating deposition 
For the experiments commercially pure titanium (cpTi) disc were provided with various Ca-P 
sputter coatings. The discs measured 1mm in thickness and had a diameter of 12 mm. All 
discs were A^C^-blasted on one side. 
RF magnetron sputter coatings were made by using a commercially available RF sputter 
deposition system provided with two separate targets (Edwards ESM 100). The target 
materials were dicalcium pyrophosphate (ß-Ca2P207) and hydroxylapatite (CasiPO^sOH) 
granules (diameter 0.5-1.0mm). The test specimens were mounted on a rotating and water-
cooled substrate holder. The distance between target and substrate was 80 mm. Before 
sputtering the metal substrates were cleaned by etching for 10 min with argon ions. During 
deposition, the argon pressure was kept at 5 xlO"3 mbar. The composition of the target 
materials were characterized after sputtering by energy dispersive spectroscopy (Table 1). 
In total five coating groups were prepared: 
1 HA; at a discharge power of 400W for both targets; 
2. mixture HA/Pyro; at a discharge power of 600W for the HA target and 200W for DCPP 
target; 
3. mixture HA/Pyro; at a discharge power of resp. 400W and 400W; 
4. mixture HA/Pyro; at a discharge power of resp. 200W and 600W; 
5. Pyro; at a discharge power of 400W for both targets. 
Coating thicknesses of 2μΓη were produced and the deposition rate for Pyro and HA was 
analyzed with a step measurement. The results are listed in Table 2. 
After deposition, half of the coated specimens were subjected to an additional infrared heat 
treatment (HT) for 30 sec at 550, 650 and 750°C (Quad Ellipse Chamber, Model E4-10-P, 
Research Inc.). 
Before and after annealing, coatings were characterized as follows: 
- The crystallographic structure of each film was determined by thin film X-ray diffraction 
(XRD) using a Philips Θ-2Θ diffractometer using a CuKa -radiation; 
- The infrared spectra of the films on the substrates were obtained by reflection Fourier 
transform infrared spectroscopy (FTIR)(Perkin-Elmer); 
- The surface topology of the films was examined using scanning electron microscopy 
(SEM) using a Jeol JSM-35. 
The elemental composition of the films was determined with an energy dispersive 






























The XRD patterns of the as-sputtered coatings showed an amorphous structure with no clear 
peaks, only the underlying substrate peaks were visible (Figure la-d) 
At 550oC, the amorphous coating HA was transformed into a crystalline apatite structure 
with main reflection lines at (002), (211) and (112), which correspond to peaks at 25 9°, 
31 9° and 32 4° (2-Theta) The amorphous HA/Pyro (600W/200W) changed into two 
crystalline phases, an apatite structure with peaks at 25 9°, 31 9° and 32 40(2-Theta) and a 
beta-calcium pyrophosphate structure with peaks at 26 6°, 27 7° and 29 5° (2-Theta) 
HA/Pyro (400W/400W) coatings alter into three crystalline phases, an apatite structure with 
peaks at 25 9°, 31 9° and 32 4°(2-Theta), a beta-calcium pyrophosphate structure with peaks 
at 26 6°, 27 7° and 29 5° (2-Theta) and a beta-tricalcium phosphate structure with peaks at 
25 9°, 27 7° and 31° (2-Theta) For the amorphous HA/Pyro (200W/600W) the formation of 
beta-calcium pyrophosphate could be detected, with peaks at 26 6°, 27 7° and 29 5° (2-
Theta) 
On the other hand, the Pyro coating remained unchanged and required a higher infrared heat-
treatment to obtain crystallization (Figure la-d) 
After heat treatment at 650oC, the heated HA, HA/Pyro (600W/200W), HA/Pyro 
(400W/400W) and HA/Pyro (200W/600W) coatings showed the same results as the coatings 
heated at 550°C, while the amorphous Pyro coatings changed into a crystalline beta-calcium 
pyrophosphate structure with reflections lines 201, 202, 008 and 212, which correspond to 
peaks at 26 6°, 27 7°, 29 5° and 30 7° (2-Theta) For all the coatings heated at 750oC the 
formation of T1O2 with peaks at 27 6° and 36 0° (2-Theta) appeared, and also peaks 
developed around 27 7 and 31 ° during the heat treatment, which attributed to beta-TCP 
formation 
The X-ray diffraction data of all the heat-treated coatings are listed in Table 3 
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Table 3 The phase composition of the sputtered coatings at different discharge power 
ratio at different annealing temperature from XRD analysis 
Discharge 
(HA:Pyro: 
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Figure la: XRD patterns of as-sputtered and heat-treated HA coatings, two target at a discharged power of 
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Figure lb: XRD patterns of as-sputtered and heat-treated HA-Pyro coatings, at a discharged power of 
HA/Pyro= 600W/200W. (A: apatite, P: dicalcium pyrophosphate, T; beta-tricalcium phosphate, TiOj: 
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Figure 1c: XRD patterns of as-sputtered and heat-treated HA-Pyro coatings, at a discharged power of 
HA/Pyro= 400W/400W. (A: apatite, P: dicalcium pyrophosphate, T: beta-tricalcium phosphate, TÌO2: 
titaniumoxide and S: titanium substrate). 
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Figure Id: XRD patterns of as-sputtered and heat-treated HA-Pyro coatings, at a discharged power of 









^«««.••»Κ*......^.«^*^"!""" **** *****" 
20 22 24 26 34 36 38 28 30 32 
2Theta (°) 
Figure le: XRD patterns of as-sputtered and heat-treated Pyro coatings, two target at a discharged power of 






FTIR measurements showed for all the amorphous coatings two clusters of bands from 900-
1200 and from 500-600 cm"' attributed to the major absorption modes associated with the 
presence of phosphate (Figure 2a-d). 
Infrared heat-treatment at 550°C. 
FTIR of the HA and HA/Pyro (600W/200W) coatings resulted in the appearance of the 
hydroxy! band at 630 cm"', characteristic for hydroxylapatite and the appearance of various 
P-O bonds at a wavelength of 567, 587, 965, 1009, 1083 cm'. The spectrum of the heat 
treated HA/Pyro (400W/400W) and HA/Pyro (200W/600W) coatings revealed characteristics 
of a mixture of apatite and beta-calcium pyrophosphate phases with various P-0 bonds at 
567, 587, 965, 1009, 1083, 1095, 1125, 1163 and 1202 cm'. The Pyro coatings resulted in 
the appearance of various P-O bonds at the wavelength around 567, 644, 965, 1009, 1083, 
1095, 1125, 1163 and 1202 cm', which are characteristic for the beta-calcium pyrophosphate 
structure. [21] 
Infrared heat-treatment at 650oC. 
FTIR showed identical FTIR spectra as obtained after the heat treatment at 550oC. 
Infrared heat-treatment at 750°C. 
At this temperature only a change of the Pyro coating could be observed. The spectrum 
showed various P-O bonds at the wavelength around 551, 571, 596, 947 and 975 cm', which 
are characteristic for the beta-tricalcium phosphate. 
Scanning electron microscopy 
SEM examination showed that, besides the HA/Pyro (200W/600W) coating, all the other 
amorphous coatings resulted in a uniform coverage of the titanium substrate, In contrast, the 
HA/Pyro (200W/600W) had a different morphology, i.e. the surface crystals grew vertically 
on top of the coating. (Figure 3g). 
SEM revealed that at 550°C no changes of the morphology of heated coatings were observed. 
On the other hand, at 650oC the HA/Pyro (200W/600W) and the Pyro coatings changed in 
morphology (Figure 3a-f)· During the heat treatment the plate-like crystals of the HA/Pyro 
(200W/600W) coatings melted, resulting in a smooth appearance of the coating (Figure 3h). 
The surface morphology of the heated Pyro coating was characterized by a flat appearance 
with micropores and needle-like crystals due to the melting and recrystallization of the 
coating (Figure 3j). At 750oC, no further change in the morphology could be found. 
EDS analysis of the different coatings are listed in Table 4. 
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Β 
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Figure 2a-b: IR spectra of as-sputtered and heat-treated Ha and Ha/Pyro coatings, (A) two target at ι 
discharged power of 400W and (B) at a discharged power of HA/Pyro= 600W/200W. 
Figure 2c-d: IR spectra of as-sputtered and heat-treated Ha/Pyro coatings, (C) at a discharged power of 
HA/Pyro- 400W/400W and (D) at a discharged power of HA/Pyro= 200W/600W. 
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Figure 2e:IR spectra of as-sputtered and heat-treated Pyro coatings, two target at a discharged power of 400W. 
a: HA coating b: HA coating-HT 
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c: HA/Pyro=600W/200W coating d: HA/Pyro=600W/200W coating-HT 
g: HA/Pyro=200W/600W coating h: HA/Pyro=200W/600W coating-HT 
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Figure 3a-j: SEM micrographs of magnetron sputtered Ca-P coatings, as sputtered and heat-treated at 
65(rC. (lOOOx) 

















































The aim of this study was to investigate the applicability of RF magnetron sputter sputtering 
for the production of mixtures of hydroxylapatite and calcium pyrophosphate coatings on 
titanium substrates. The results demonstrated that it is possible to deposit dense and adherent 
mixtures of hydroxylapatite and calcium pyrophosphate coatings by choosing the appropriate 
deposition parameters. 
RF magnetron sputter deposition is a rather complex process to describe in physical 
parameters, especially when used to sputter multi-compounds like hydroxylapatite and 
pyrophosphate. There are, besides target composition, two main process parameters, which 
can be varied to influence the physical and chemical properties of the coating: working gas 
pressure and discharge power. In our study, we changed the discharge power and the Argon 
pressure was kept constant. In literature, there is discrepancy about the exact process of 
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building a layer It is generally accepted that during the sputtering process the deposited 
layers are build up atom for atom or ion for ion Although other researchers found that 
particles are ejected as a neutral and as a negatively particle, they suggested that Phosphorus 
and Calcium were ejected as neutral, while Oxygen was escaped from the target as a negative 
ion [25] We observed that besides all the mentioned particles, also clusters of phosphate 
materials are sputtered XRD revealed that a mixture of crystalline pyro and hydroxylapatite 
coatings (400w/400w) consisted of an apatite, beta-pyrophosphate and beta-
tricalciumphosphate structure The Ca/P ratio of this coating is 1 5, when a coating is build up 
from atoms or ions, the heat treatment of this coating will only result in the formation of a 
tricalcium phosphate In this study, we found a mixture of several phases and therefore we 
assume that molecules and clusters of ortho- and pyrophosphate materials play an important 
role in building a calcium phosphate layer 
The EDS analysis showed that the Ca/P ratio of the sputtered coatings was higher than the 
theoretical values for HA and HA/Pyro (600W/200W and 400W/400W) coatings and lower 
for the HA/Pyro (200W/600W) and Pyro coatings Concerning the high Ca/P ratio of the 
coatings, several studies have been published where preferential sputtering of calcium was 
observed, probably due to the possibility of the phosphorus ions being pumped away before 
they are deposited on the substrate [26] An explanation for the decrease in Ca/P ratio of the 
other coatings is the structure of the pyrophosphate anion It has been published that 
pyrophosphates have a great tendency to occur in polymorphic phases and to consist of two 
?OA tetrahedral bridged by a mutual oxygen atom [27] Consequently, we hypothesize that 
the possibility of pyrophosphate ions being pumped away during sputtering is very low, due 
to the complex structure as compared to the orthophosphate anion Further, it has to be 
noticed that PO4 reaches the substrate surface easier and is much more volatile than Ca ions 
[28,29] Also the impact of a particle with the target material may lead to structural 
rearrangements such as the introduction of interstitials or vacancies It may also introduce 
lattice defects such as stoichiometry modifications In our sputtering system, we observed a 
preferential sputtering of the outer layer of the target material, the Ca/P ratio of the 
pyrophosphate target increased in time from 1 0 to 1 56, while for the hydroxylapatite target 
material a decrease was found (1 67 to 1 1) It is clear that a cascade of events occurs during 
sputtering of calcium phosphate materials As a result, the exact mechanism of how the 
sputtered layer is build up, is not completely understood Therefore, research efforts in this 
area should have more attention 
Furthermore, the crystallization of the amorphous as sputtered coatings is depending on the 
temperature during infrared heating At 650oC or higher the XRD all the amorphous coatings 
showed a crystalline structure Further, the post heat treatment at 750oC resulted in an 
increase of thickness of the T1O2 layer This increase is not considered to be a disadvantage 
for the long-term bone response It has already reported that the growth of the titanium oxide 
layer can even enhance the bonding to bone [30] 
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Finally, XRD analysis demonstrated that the mixing of HA and Pyro resulted in the formation 
of beta-tncalcium phosphate phase From literature, it is known that apatite and 
pyrophosphate forms tncalcium phosphate around 650oC according to the following reaction 
[31]· 
Ca,o(P04)6(OH)2 + Ca2P207 -> 4Ca1(P04)2 + H2O 
It has been described that tncalcium phosphate is generally considered as a more resorbable 
biomaterial than dense hydroxylapatite and is used to overcome the low biodégradation of 
hydroxylapatite 
Conclusion 
Based on the results of this study, it can be concluded that magnetron sputtering can be 
successfully used to deposit dicalcium pyrophosphate and hydroxylapatite coatings on metal 
substrates All the as-sputtered coatings were amorphous and after IR-irradiation the coatings 
altered into a crystalline phase The crystallization temperature of amorphous pyrophosphate 
coating is higher as compared to amorphous hydroxylapatite coating The obtained coatings 
had a Ca/P ratio varying from 0 55 to 2 0 and different phase compositions or mixtures of 
apatite, beta-pyrophosphate and beta-tncalciumphosphate structures were formed The phase 
compositions of the sputtered coatings are determined not only by the discharged power ratio 
of the hydroxylapatite and dicalcium pyrophosphate target, but also by the annealing 
temperature These results suggest that magnetron sputtering of mixtures of apatite and 
calcium pyrophosphate coating is a promising method for forming a ceramic coating 
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In vitro evaluation of different heat-treated RF magnetron sputtei ed calcium phosphate coatings 
Introduction 
With the advances in ceramics technology, many kinds of synthetic calcium phosphate (Ca-
P) materials have been used as bone substitutes These materials have been prepared and 
studied extensively in vitro and in vivo [1-3]] Beside hydroxylapatite (HA), a naturally 
occurring mineral and the predominant mineral component of vertebrate bone and tooth 
enamel, tncalcium phosphate (TCP) has also been widely used in the clinical applications [4, 
5] Although some materials used have been called "hydroxylapatite" by some investigators, 
they actually vary widely in composition with calcium/phosphorus ratios ranging from 2 0 to 
as low as 1 3 Therefore, it can be difficult to compare and rationalize the results of studies by 
different investigators with "hydroxylapatite" materials [6, 7] The previous studies showed 
that except the calcium phosphate primary (CaiPhPO^), which is too acidic, most other CaP 
ceramics are biocompatible [8-10] Meanwhile bone responses to the implant surface are 
affected not only by the surface chemical compositions but also by the surface structure and 
morphological properties [11-14] Usually HA is considered as the end product of the 
biological mineralization process, while dicalcium pyrophosphate (DCPP) with a formula of 
Ca2P207 is one of the intermediate products in this process [15] Although many studies 
suggested that crystalline dicalcium pyrophosphate is biocompatible, little is known about 
DCPP coating properties in vitro and m vivo On the other hand, due to their brittle nature the 
bulk Ca-P ceramics have been proposed to be applied as thin coatings on metallic substrates, 
resulting in implants that have the excellent biocompatible properties of calcium phosphate as 
well as the advantageous mechanical properties of metal [16, 17] Previously our group 
investigated the use of radio frequency (RF) magnetron sputter deposition as a method of 
applying thin adherent calcium phosphate coatings to titanium implants [18-20] The results 
have shown that both calcium pyrophosphate and hydroxylapatite films deposited are 
amorphous and change into a crystalline structure after heat treatments of either infrared or 
water steam [21 ] The morphological properties and the compositions are different after these 
heat treatments, which can result in a different biological response 
Consequently, the objective of the present study was to compare the response of different 
heat-treated Radio Frequent (RF) magnetron sputtered CaP surfaces in simulated body fluid 
(SBF) as well as the behavior of bone-like cells on these surfaces 
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Materials and Methods 
Ca-P coating deposition 
Ca-P sputter coatings were applied onto commercially pure titanium (cpTi) discs The discs 
were cut from cpTi rods with a diameter of 12 mm and a thickness of 1mm The discs were 
then subjected to an aluminium oxide gnt blasting procedure and subsequently cleaned with 
ethyl alcohol rinses The final roughness (Ra)-value of the surfaces was 1-13 μιτι The 
following coatings were provided on the discs with a commercially available RF sputter 
deposition system (Edwards ESM 100) 
Calcium pyrophosphate with a thickness of 2 μιτι (A-DCPP), 
Hydroxyapatite with a thickness of 2 μπι (A-HA) 
The target materials were calcium pyrophosphate (ß-Ca2P207) and hydroxylapatite 
(Ca5(P04)30H) granules (diameter 0 5-1 0mm) The test specimens were mounted on a 
rotating and water-cooled substrate holder The target to substrate distance was 80 mm 
Before sputtering the metal substrates were cleaned by etching for 10 mm with argon ions 
During deposition, the argon pressure was kept at 5 xlO3 mbar and the sputter power was 
400W 
After deposition, one third of the coated specimens were subjected to an additional infrared 
heat treatment for 30 sec, the HA coatings were heated at 550oC (I-HA) and the DCPP 
coatings at 650oC (I-DCPP) (Quad Ellipse Chamber, Model E4-10-P, Research Ine) The 
other one third of the coated specimens were heated at 140oC and 0 4 MPa in water steam, 
the HA coatings for 8 hours (S-HA) and the DCPP coatings for 16 hours (S-DCPP) 
Before and after the different heat treatments the deposited films were characterized using the 
following techniques 
The crystallographic structure of each film was determined by thin film X-ray diffraction 
(XRD) using a Philips Θ-2Θ diffractometer using a CuKa -radiation The infrared spectra of 
the films on the substrates were obtained by reflection Fourier transform infrared 
spectroscopy (FTIR)(Perkin-Elmer) The surface topology of the films was examined using 
scanning electron microscopy (SEM) using a Jeol JSM-35 The elemental composition of the 
films was determined with energy dispersive spectroscopy (EDS) 
In vitro bioactivity assay 
Coated specimens were incubated in 4 ml Simulated Body Fluid buffer (SBF) with a pH of 
7 2 at }>1°C for 4 weeks (Table 1) For each treatment procedure, the expenment was 
performed in triplicate and SBF was refreshed once a week At the end of the experiment, 
coated samples were retrieved out of the SBF solution After rinsing in aqua and drying at 
room temperature, the specimens were characterized by using XRD, FTIR, SEM and EDS 
For each sample, the Ca and Ρ concentration in the solutions was determined in triplicate by 
ICP (Inductively Coupled Plasma) 
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Buffered with tns(hydroxymethyl) aminomcthane (50mM), set at pH 7 2 with 1 ON hydrochloric acid (Li 1993). 
Rat bone marrow cell assay 
Rat bone marrow (RBM) cells were isolated and cultured using the method desenbed by 
Maniatopoulos [22]. RBM cells were obtained from femora of male Wistar rats. Femora were 
washed 4 times in culture medium a-MEM (Minimal Essential Medium; MEM Gibco BRL, 
Life Technologies B.V. Breda, The Netherlands) with 0.5-mg/ml gentamycin and 3 μg/ml 
fungizone. Epiphyses were cut off and diaphyses flushed out with 15 ml culture medium a-
MEM, supplemented with 10 % FCS (foetal calf serum, Gibco), 50 μg/ml ascorbic acid 
(Sigma, Chemical Co., St.Louis, MO, USA), 50 μg/ml gentamycin, 10 mM Na ß-
glycerophosphate (Sigma) and 10~8 M dexamethasone (Sigma). Cells were incubated in a 
humidified atmosphere of 95 % air, 5 % CO2 at 37°C. The medium was changed every two or 
three days. 
After 6 days of primary culture, cells were detached using trypsin/ EDTA (0.25% w/v 
trypsin/0.02% EDTA). The cells were concentrated by centrifugation at 1500 rpm for 5 min. 
and resuspended in a known amount of media (5 ml). Cells were counted by a Coulter® 
counter and resuspended in medium (2.0 χ 10 5 cells/1000μ1). The cell suspension was used 
for the seeding and culturing experiments. 
Cells were presented to the various substrates in a cell suspension. The substrates were 
seeded with 2.0 χ IO4cells/ΙΟΟΟμΙ). Substrates with cells were cultured in 24-wells plate for 
8 and 16 days. The medium was changed every two or three days. 
At the end of the incubation times, samples were taken out of the well-plates and washed 
twice with PBS. Subsequently, cells were fixed for 30 minutes in 2% gluteraldehyde, and 
then substrates were washed twice with 0.1 M sodium-cacodylate buffer (pH 7.4), dehydrated 
in a graded series of ethanol and dried by tetramethylsilane. The specimens were sputter-
coated with gold and examined and photographed using a Jeol 6310 SEM at an acceleration 
voltage of lOkV. 
Results 
Surface phase changes of the Ca-P sputtered coatings after incubation in SBF 
Figure 1 shows the XRD patterns of the sputtered coatings before and after incubation in 
SBF. As-sputtered HA coating heated at 550oC with infrared radiation showed a crystalline 
apatite structure with reflections at 002, 211, 112, 202, resp. 25.9°, 31.9°, 32.4° and 34.0° 2-
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Theta, which is comparative with the XRD pattern of HA powder (JCPDS #09-0432). The 
sputtered amorphous pyrophosphate coating required an annealing temperature of 650oC to 
alter into crystalline beta-calcium pyrophosphate structure with reflection lines 201, 202, 008 
and 212, which correspond to peaks at 26.6°, 27.7°, 29.5° and 30.7° in 2-Theta (JCPDS#09-
0346). The four week incubation of Α-HA coatings in SBF resulted in the formation of small 
peaks around 25.9°, 26.6°, 31-33°, indicating apatite formation (Figure la). In contrast, no 
peaks appeared for A-DCPP coatings during SBF incubation (Figure Id). The I-HA and S-
HA coatings showed a stable XRD pattern during the incubation (figure lb, 1c). For the 1-
DCPP coatings, peaks appeared around 25.9°, 29° and 31°, which indicate the transformation 
of calcium pyrophosphate into a tricalciumphosphate (TCP) phase (Figure le). For the S-
DCPP coatings, peaks developed around 27.7 and 31° during SBF incubation, which could be 
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Figure la: XRD patterns of amorphous HA coating after 4 weeks incubation in SBF at 
37" C. (A: apatite and S: titanium substrate). 
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Figure lb: XRD patterns of infrared heat-treated HA coating after 4 weeks incubation in SBF at 37° C. (A: 
apatite and S: titanium substrate). 
Figure 1c: XRD patterns of steam heat-treated HA coating after 4 weeks incubation in SBF at 37° C. (A: apatite 
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Figure Id: XRD patterns of amorphous DCPP coating after 4 weeks incubation in SBF at 
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Figure Id: XRD patterns of amorphous DCPP coating after 4 weeks incubation in SBF at 
37° C. (P: dicalcium pyrophosphate, T: beta-tricalcium phosphate and S: titanium substrate). 
DCPP 
73 
In vitro evaluation of different heat-treated RF magnetron sputtered calcium phosphate coatings 
l-DCPP 
• • • • • 
20 22 24 26 28 30 32 
2Theta (0) 
Figure le: XRD patterns of infrared heat-treated DCPP coating after 4 weeks incubation in SBF at 37° C. (P: 
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Figure le: XRD patterns of steam heat-treated DCPP coating after 4 weeks incubation in SBF at 37° C. (P: 
dicalcium pyrophosphate, T: beta-tricalcium phosphate and S: titanium substrate). 
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CaP coating surface structure changes before and after incubation in SBF 
Figure 2 depicts the FTIR spectra of the as-sputtered, heated and SBF incubated coatings. All 
as-sputtered DCPP and HA coatings show two clusters of peaks from 900-1150 and from 
550-600 cm'1, which can be attributed to the major absorption modes of phosphate bonds 
(Figure 2). During incubation in SBF, these peaks decreased in size, indicating dissolution of 
these amorphous coatings (Figure 2a, 2d). Infrared heat treatment of the DCPP coatings 
resulted in the appearance of various P-0 bonds that did split up into many peaks at a 
wavelength around 1300 to 950 cm', which is characteristic for the beta-calcium 
pyrophosphate structure. I-HA coatings showed the appearance of the various P-0 bonds at a 
wavelength of 948, 965, 1009, 1083, and 1124 cm'1, which is characteristic for an apatite 
structure. During soaking in SBF, a weak peak developed around 1470 cm' for both I-HA 
and S-HA coatings indicating the formation of carbonated apatite (Figure 2b, 2c). 1-DCPP 
and S-DCPP coatings showed stable FTIR spectra, almost no changes could be observed 
during immersion in the SBF (Figure 2e, 2f). 
1500 1000 500 1500 1000 500 
cm-1 cm-1 
Figure 2a-b: IR spectra of Ha coatings after 4 weeks incubation in SBF at 37' C. (A) as-sputtered coatings and 
(B) infrared heat-treated coatings 
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Figure 2c-d: IR spectra of Ha and DCPP coatings after 4 weeks incubation in SBF at 37' C. (C) steam heat-




Figure 2e-f: IR spectra of Ha and DCPP coatings after 4 weeks incubation in SBF at 37° C. (E) infrared heat-
treated coatings and (F) steam heat-treated coatings. 
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Compositional changes of the sputtered CaP coating surfaces during incubation in SBF 
Table 2 lists the Ca/P ratio changes of the coating surfaces before and after incubation in SBF 
as determined by Energy Dispersive Spectroscopy The Ca/P ratio of both amorphous HA 
and DCPP coatings was found to change significantly The Ca/P ratio of the A-Η A coatings 
changed from 2 0 to 1 12, and the Ca/P ratio of the A-DCPP coatings from 0 76 to 1 23 In 
contrast, the Ca/P ratio of the I-HA coating changed less, ι e from 2 01 to 1 76, and the Ca/P 
ratio of the S-HA coatings changed from 1 91 to 1 68 after incubation in the SBF For both I-
HA and S-HA coatings, the changes in Ca/P ratio mainly occurred dunng the first week of 
incubation Further, the Ca/P ratio of the I-DCPP coatings increased gradually during 
incubation, ι e from 0 76 to 1 26 while the Ca/P ratio of S-DCPP coatings remained more or 
less stable around 1 5 during incubation in SBF 











































ICP measurements of Ca and Ρ concentration changes in the SBF 
Figure 3 and 4 show the calcium and phosphate concentration for the different calcium 
phosphate coatings in SBF buffer during the 4 week incubation period 
For the amorphous coatings, an increase of Ca concentration was observed up to 3 weeks of 
incubation Thereafter, the Ca concentration remained stable The Ρ concentration m the SBF 
increased up to 4 weeks of incubation 
In contrast with the amorphous specimens, all heat-treated coatings adsorbed Ca and Ρ within 
the 4 week incubation period, which is charactenzed by a slight decrease in Ca as well as Ρ 
concentration during the immersion in SBF 
Surface morphology changes of the CaP coatings after soaking in SBF 
SEM pictures of the as-sputtered, heated and SBF incubated coatings are shown in Figure 5 
SEM examination of the as-sputtered coatings showed an excellent coverage of the substrate 
surface (Figure 5a, 5d) Infrared heat treatment induced no changes in the coating 
morphology (Figure 5b, 5e), while steam heating resulted in the deposition of a precipitate on 
the coated surface (Figure 5c, 5f) After incubation in SBF, the amorphous coatings dissolved 
almost completely (Figure 6a, 6d), while both I-HA and I-DCPP coatings did not show any 
change during the incubation in SBF (Figure 6b, 6e) On the other hand, on the S-HA and S-
DCPP surfaces precipitation was seen with a different morphological structure compared 
77 
In vitro evaluation of different heat-treated RF magnetron sputtered calcium phosphate coatings 














Figure 4 Phosphate concentration measurements in SBF 
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Figure 5 SEM micrographs of different sputtered CaP surface; 
A: Α-HA surface, B: I-HA surface, C: S-HA surface, D: A-DCPP surface, 
E: I-DCPP surface and F: S-DCPP surface 
m 
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Figure 6 SEM micrographs of different CaP surfaces after incubation in SBF for 4 weeks; 
A: Α-HA surface, B: I-HA surface, C: S-HA surface, D: A-DCPP surface, 
E: I-DCPP surface and F: S-DCPP surface 
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Behavior ofRBM cells on the various CaP coatings 
SEM confirmed the presence of cells on all four types of heat-treated CaP coating at both 
incubation times. Nevertheless, clear differences were seen. On the I-HA coatings, the cells 
proliferated well and formed a multilayer of cells with extensive collagen fibre formation and 
surface mineralization in the form of globular accretions (Figure 7a). On the S-HA surfaces, 
the cell proliferation was combined with the deposition of very fine mineralization particles 
(Figure 7b). The same was observed for the S-DCPP coatings, although the number of cells 
appeared to be somewhat less. On the I-DCPP surface a multilayer of cells was observed, but 
the deposition of calcified globuli was very limited. 
Additional EDS measurements showed that the Ca/P ratio of the I-HA coating decreased to 
1.96 + 0.05 at day 8 and 1.91+0.05 at day 16, while the Ca/P ratio of the S-HA coatings 
remained stable at 1.77 + 0.02 during incubation. The Ca/P ratio of the I-DCPP coatings at 8 
days was found to be 1.15 ±0.01 and at 16 days 1.23 + 0.02, while the Ca/P ratio of S-DCPP 
coatings increased to 1.52 + 0.01 at day 8 and 1.51+0.01 at day 16 of incubation. 
Figure 7 SEM micrographs of RBM cells after 16 days of incubation on different CaP; surfaces. A: I-HA 
surface, B: S-HA surface. C; I-DCPP surface and D; S-DCPP surface. 
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Discussion 
Based on the results, we have clearly seen that in vitro behavior of RF sputtering CaP 
coatings is strongly affected by the surface characteristics induced by different heat 
treatments As-deposited RF sputtered CaP coatings are amorphous and need heat treatment 
to obtain crystalhmty [23] As a consequence, incubation of as-sputtered CaP coatings in 
simulated body fluid (SBF) results in partial dissolution of the surface This process is 
initiated by the release of Ca2+, HP042 and P043 This exchange of ions from the coating 
surface continues until the concentration of Ca2+, HP042 and P043 reaches supersaturation, 
then the dissolution and precipitation equals When the SBF is refreshed, the equilibrium is 
broken and the dissolution restarts In this way the RF sputtered amorphous CaP coatings 
dissolve gradually in the SBF Although HA is considered the most stable phase among all 
the calcium phosphate phases in a SBF environment, the amorphous HA coatings show 
dissolution in the SBF, similar to the amorphous pyrophosphate coatings 
Therefore, post-heat treatment is an essential process to control the crystalhnity and 
morphology of the CaP coatings However, different heat treatment procedures can have a 
great influence on the morphology and interfacial properties of the coating surface, which can 
influence the surface reaction in SBF Heat treatment at a high temperature (e g, above 
600oC) in air reduces the adhesive strength of a sputtered CaP coating to the underlying 
substrate surface and can even result in the buckling of the coating at the surface Also it is 
known, that with increasing temperature of the heat treatment, the purity of the HA phase in 
the coating decreases [19, 24] To avoid alteration of the basic properties of sputtered CaP 
coatings, we decided to heat the coatings either with infrared at high temperature (500-
700oC) for a very short time (30 seconds) or water steam at a lower temperature for a long 
time (140°C) The results showed that both infrared and water steam heat treatment changed 
the amorphous coating into the crystalline phase After the different heat treatment 
procedures, the sputtered CaP coatings were stable in SBF and CaP crystals nucleated on the 
surface [25] In our present study, the I-HA coatings had an initial Ca/P ratio 1 97, which 
indicates the presence of a surplus of positive ions (Ca2+) Consequently, the negative ions as 
present in the SBF, like CO32 and HP04 2 , will be attracted to the coating surface This is 
followed by an accumulation of positive ions in SBF and their subsequent precipitating on the 
surface During this process, ions exchange and gradually a hydroxy-carbonate apatite (HCA) 
layer is formed On the other hand, the formation of TCP phase within the heat treated DCPP 
coatings is the result of the surface reaction of calciumpyrophosphate into a ß-TCP phase 
This result is in line with observations of Yubao et al [26], who found that pyrophosphate 
reacts with a hydroxyl group and ß-TCP is formed 
P2O74 + OH - • 2PO43 + H2O 
Further, the DCPP coating showed a deficit of Ca2H (Ca/P ratio of 0 76) Therefore, this 
surface has a high initial affinity for positive ions, like Ca2+ and Mg2', after incubation in 
SBF, which is followed by the deposition of a TCP and HA phases Occasionally, it is 
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claimed that this kind of reactions on CaP surfaces has bone-like characteristics 
Nevertheless, we have to emphasize that a lot of major bone components (like cells, 
collagen, blood vessels) are lacking [27, 28] In view of this, the deposit can only be 
considered as a more natural matrix for osteoblast adhesion and differentiation 
Further, the changes in Ca/P ratio of both Α-HA and A-DCPP coatings indicated that these 
surfaces are chemically unstable in SBF, resulting in a decrease in Ca/P ratio for Α-HA and 
an increase for A-DCPP coatings Meanwhile, the Ca/P ratio of I-HA and S-HA surfaces 
showed a tendency to change into the direction of stochiometnc HA, ι e 1 67 A similar trend 
was observed for the heat treated DCPP surfaces This agrees with the existing theories, since 
the crystal HA phase is the most stable phase in SBF [29] All changes could be associated 
with changes in the Ca and Ρ concentration of the SBF Evidently, a relation exists between 
change in coating Ca/P ratio and the deposition of a precipitate out of the SBF The SEM 
photographs of infrared steam heated CaP surfaces indicated that much more precipitate was 
formed on S-HA surface as well as S-DCPP surfaces compared with the infrared treated 
coatings 
Our previous study showed that amorphous DCPP and HA coatings did not support the 
proliferation and differentiation of rat bone marrow cells [30] In the current study, some 
significant differences were observed on the various heated CaP coating surfaces On both I-
DCPP and I-HA coatings, a thick multilayer of bone-like cells was seen Also, on the S-HA 
and S-DCPP coatings, the cells did proliferate and differentiate Nevertheless, the 
morphology of the cells and mineral deposit differed compared with the infrared heated 
coatings We suppose that this is still due to small differences in the dissolution properties of 
these coatings All these results corroborate with our earlier studies dealing with the behavior 
of bone marrow cells on magnetron sputtered CaP coatings [31 ] The EDS measurement of 
the Ca/P ratio of the coatings after cell cultunng revealed for S-HA, I-DCPP and S-DCPP 
coatings similar changes occurred as for the SBF incubated specimens Only for I-HA 
coatings the Ca/P ratio after 16 days of cultunng was higher compared with the SBF 
incubated ones Again, this can be due to small differences in dissolution behavior associated 
with coverage by the cell layer and at the same time deposition of mineralized matrix by the 
bone-like cells This explanation is supported by an earlier study with very thin highly 
crystalline magnetron deposited coatings [29] This study proved that incubation in SBF as 
well as incubation in cell cultures and the subsequent deposition of a calcified layer are two 
different phenomena 
Conclusion 
Overall, we conclude that different heat treatment procedures for the sputtered HA and DCPP 
coatings influences the surface charactenstics of these coatings, whereby a combination of 
crystallinity and specific phase composition (Ca/P ratio) strongly affect the in vitro 
bioactivity of sputtered CaP coatings This conclusion is supported by or observation that 
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Both sputtered amorphous Α-HA coating and A-DCPP coatings are chemically active in SBF 
and release Ca and Ρ into the SBF. In contrast, heat treated surfaces release less Ca and Ρ as 
well as a precipitate is formed on these surfaces. 
The Ca/P ratio of heat treated HA and DCPP coatings shows a tendency to change into the 
direction of stoichiometic HA during incubation in SBF. 
Rat bone marrow cells can proliferate and differentiate on heat treated HA and DCPP 
coatings. 
Finally, it has to be noticed that SBF incubation studies are not completely comparable with 
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Introduction 
Worldwide an estimated number of 1 million patients annually need implants (orthopedic 
and, or dental) for the replacement of joints of natural teeth Treatment does not always result 
in a solution For example, loosening occurs in 5-40% of the inserted orthopedic and dental 
implants [1,2] This situation is attributed to inadequate local bone conditions and impaired 
bone healing 
Bone formation is a complex process that involves proliferation of osteoprogemtor cells, their 
differentiation into osteoblasts, finally resulting in the secretion of abundant bone matrix 
proteins, which coordinate the mineralization process [3-7] In view of the bone formation 
process, it is known that most so-called bioactive implant materials show a direct bone 
bonding through a calcified layer at the implant interface One of the preferred bioactive 
materials for the manufacturing of bone replacing devices is the calcium phosphate ceramic 
hydroxylapatite (HA) The favorable bone response of this material is supposed to be due to 
its similarity in terms of chemical composition and crystal structure with the calcium 
phosphate phase of bone mineral [8-11] However, on basis of the structural arrangement of 
bone and the sequence of the biological mineralization process, it can be reasoned that 
besides HA other calcium phosphate ceramics, like dicalcium phosphate and pyrophosphate, 
play an important role in the bone formation towards implant surfaces [ 12] For example, HA 
has to be considered as the end product of the biological mineralization process, while 
dicalcium pyrophosphate (Ca2P207; DCPP) is one of the intermediate products in this 
process[13] 
To support and explore this hypothesis, in previous studies dicalcium pyrophosphate coatings 
were obtained by RF magnetron sputter deposition and the physicochemical as well as 
dissolution behavior of these coatings was determined in simulated body fluid (SBF) [14, 15] 
The results showed that DCPP coatings displayed similar properties as HA in the SBF, also 
heat-treated coatings appeared to be more stable in the SBF than amorphous coatings 
The aim of the present study was to evaluate the in vitro cell behavior of RF magnetron 
deposited DCPP coatings in companson with HA coatings We hypothesized that the 
proliferation and differentiation of bone-like cells on DCPP surfaces would be at least very 
similar to HA surfaces 
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Materials and Methods 
Substrates 
For the experiments commercially pure titanium discs with a diameter of 12 mm and 
thickness of 1.5 mm were used. All discs were A^Os-blasted on one side (Ra =1.0-1.3μιτι). 
After ultrasonic cleaning in isopropanol, the discs were provided with the following coa­
tings: 
Dicalcium pyrophosphate coating, with a thickness of 2 μιτι; 
- Hydroxylapatite coating, with a thickness of 2 μπι. 
The coating procedure was performed using a commercially available RF magnetron sputter 
unit (Edwards ESM 100, Crawford, England). The target material used in the deposition 
process was a copper disc provided with either pyrophosphate or hydroxylapatite granulate. 
The process pressure was 5 χ IO"3 mbar and the sputter power was 400 W. The deposition 
rate of the films was 100-150 nm/hour sputtering. After deposition, half of the coated 
specimens were subjected to an additional infrared heat treatment for i.e. 30 sec at 550oC for 
the HA coatings and at 650°C for the DCPP coatings. Before and after heat-treatment, the 
coatings were characterized by thin film X-ray diffraction (Philips, PW3710, Almelo, The 
Netherlands), Fourier transform infrared (FTIR, Perkin Elmer, Fremont, CA, USA) and a 
scanning electron microscope (SEM, Jeol 6310, Tokyo, Japan) equipped with an energy 
dispersive spectroscope in order to determine the coating Ca/P ratio. 
Cell isolation 
Rat bone marrow (RBM) cells were isolated and cultured using the method described by 
Mamatopoulos [16]. RBM cells were obtained from femora of male Wistar rats. Femora were 
washed 4 times in culture medium a-MEM (Minimal Essential Medium; MEM Gibco BRL, 
Life Technologies B.V. Breda, The Netherlands) with 0.5-mg/ml gentamycin and 3 μg/ml 
fungizone. Epiphyses were cut off and diaphyses flushed out with 15 ml culture medium a-
MEM, supplemented with 10 % FCS (foetal calf serum, Gibco), 50 μg/ml ascorbic acid 
(Sigma, Chemical Co., St.Louis, MO, USA), 50 μg/ml gentamycin, 10 mM Na ß-
glycerophosphate (Sigma) and 10~8 M dexamethasone (Sigma). Cells were incubated in a 
humidified atmosphere of 95 % air, 5 % CO2 at 370C. The medium was changed every two or 
three days. 
After 6 days of primary culture, cells were detached using trypsin/ EDTA (0.25% w/v 
trypsin/0.02% EDTA). The cells were concentrated by centrifligation at 1500 rpm for 5 min. 
and resuspended in a known amount of media (5 ml). Cells were counted by a Coulter® 
counter and resuspended in medium (2.0 χ 105 cells/1000μ1). The cell suspension was used 
for the seeding and culturing experiments. 
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Cell seeding and culturing 
Cells were presented to the substrates in a cell suspension The substrates were seeded with 
2 0 χ 104cells/ΙΟΟΟμΙ) Substrates with cells were cultured in 24-wells plate for 0 (16 hrs) to 
24 days The medium was changed every two or three days 
Two complete separate studies were performed In each study, each assay was done in 
fourfold 
DNA analysis 
DNA content was determined at day 1, 3, 5, 8 and 12 For the DNA assay, medium was 
removed and the cell layers were washed twice with PBS The substrates were put in a 10ml 
tube containing 1 ml milliQ water For isolation of the DNA, the 10ml tubes were incubated 
at 37°C for one hour After that the tubes were placed at -70oC for 2 hrs After thawing, 
samples were sonicated for 10 mm After that samples were ready for use For analysis, a 
PicoGreen dsDNS Quantitation Kit (Molecular Probes, Leiden, The Netherlands) was used, 
according to the instructions of the kit Briefly, 100 μΐ sample was added to 100 μΐ PicoGreen 
working solution After 2-5 minutes of incubation in the dark, the DNA was measured on a 
fluorescence curve reader with excitation filter 365nm and emission filter 450nm 
A Ikaline phosphatase 
Alkaline phosphatase was measured at day 1, 3, 5, 8 and 12 Medium was removed and cell 
layer was washed twice with PBS 0 5 ml of MilliQ was added to each well Cells were 
harvested in 10-ml tubes and cell suspension was sonicated for 10 mm , and then centnfuged 
at 2000 rpm, room temperature Aliquots of the supernatant were removed for determination 
of protein concentration The supernatant was stored at -20 °C until the assay was performed 
For the assay, 96 well plates were used 80 μΐ of sample and 20 μΐ of buffer solution (5 mM 
MgC12, 0,5M 2-amino-2methyl-1 -propanol) was added 100μ1 of substrate solution (5mM 
paranitrophenylphosphate) was added to the well and the plate was incubated for 1 hrs at 
370C The reaction was then stopped by adding 100μ1 of stop solution (0,3 M NaOH) For the 
standard curve, serial dilutions of 4-nitrophenol were added to final concentrations of 0 to 
25nM 80μ1 of standard and 20μ1 of buffer solution was added to the wells The plate was 
read in an ELISA reader at 405nm Samples and standards were assayed in triplicate 
Osteocalcin 
Cell layers were collected on days 8, 12, 16 and 24 Cell layers were washed twice in PBS 
scraped in 1 ml PBS and homogenized by sonication for 10 minutes Appropriate dilutions of 
this suspension were used for quantification of osteocalcin The suspension was stored at -
20oC until the assay was performed Osteocalcin was measured using an enzyme 
immunoassay kit (Biomedical Technologies Ine, Stoughton, MA, USA) Briefly, 100 μΐ of 
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sample was added to the wells and the plate was incubated at 4°C, for 24 hrs After this 
period, wells were washed 3 times with 0 3ml wash buffer 100 μΐ of osteocalcin anti-serum 
was added to the well and the plate was incubated for 1 hrs at 370C The plate was then 
washed three times and 100 μΐ of donkey anti-goat IgG peroxidase was added and incubated 
for 1 hrs at RT 1 Volume of TMB solution was mixed with 1 volume of hydrogen peroxidase 
solution The plate was washed 3 times with wash buffer 100 μΐ of substrate solution was 
added to the wells and the plate was incubated for 30 minutes at RT (in the dark) 100 μΐ of 
stop solution was added to the wells and absorbency read at 450nm Osteocalcin stock was 
diluted to generate standards from 0 25 to 20 ng/ml Samples and standards were assayed in 
6-fold 
Scanning electron microscopy (SEM) 
After day 8 and 16 of incubation, samples were washed twice with PBS Fixation was done 
for 30 minutes in 2% gluteraldehyde, then substrates were washed twice with 0 1 M sodium-
cacodylate buffer (pH 7 4), dehydrated in a graded senes of ethanol and dryed by 
tetramethylsilane The specimens were sputter-coated with gold and examined and 
photographed using a Jeol 6310 SEM at an acceleration voltage of 15kV and equipped with 
energy dispersive spectroscopy (EDS) 
Statistical analysis 
All data were statistically evaluated with GraphPad* Instai 3 05 software (GraphPad 
Software Ine, San Diego, CA, USA) using an one-way Analysis of Variance (ANOVA) 
followed by a Tukey-Kramer Multiple Comparison test for further evaluation of the data 
Differences were considered significant at p-values less then 0 05 
Results 
Coating surface analysis 
XRD characterization and Ca/P ratio of the vanous coatings is shown in Figure 1 Both HA 
and DCPP coating changed from an amorphous into an almost 100% crystalline structure 
after heat treatment with infrared at 550 °C and 650 °C for 30 seconds Heat-treated HA 
coatings had a crystalline apatite structure, as characterized the reflections 002, 211, 112, 202 
resp 25 9°, 319°, 32 4° and 34 0° 2-Theta (JCPDS #09-0432) The heat-treated DCPP 
coatings showed a crystalline beta-calcium pyrophosphate structure with reflections lines 
201, 202, 008 and 212, which correspond to peaks at 26 6°, 27 7°, 29 5° and 30 7° in 2-Theta 
(JCPDS#09-0346) 
FTIR showed for all the amorphous HA and DCPP coatings two clusters of peaks from 900-
1150 and from 550-600 cm', which can be attributed to the major absorption modes 
associated with the presence of phosphate (Figure 2) Infrared heat treatment resulted for the 
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HA sputter coatings in the appearance of the various P-0 bonds at a wavelength of 948, 965, 
1009, 1083, and 1124 cm', which are characteristic for an apatite structure. Heat treatment of 
the DCPP coatings resulted in the appearance of various P-0 bonds at a wavelength around 
1300 to 950 cm'1, which split up into many peaks that are characteristic for the beta-calcium 
pyrophosphate structure. 
The Ca/P ratios of the two types of coating were significantly different and were about 2 for 
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Figure 1: XRD patterns of the sputtered CaP coatings. The numbers indicate the major reflection lines for 
HA and dicalcium pyrophosphate. (A: apatite, P: pyrophosphate and S: titanium substrate) 
Table 1: the Ca/P ratios of the sputtered coatings surface (n = 5) 
Coatings Ca/P ratio 
Sputtered HA coatings 2.01 ± 0.05 
Sputtered HA coatings-HT 1.97 ± 0.06 
Sputtered Pyro coatings 0.76 ± 0.03 
Sputtered Pyro coatings-HT 0.76 ± 0.04 
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3000 1300 1000 450 JD 
Figure 2: FTIR spectra of the various CaP coatings before and after infrared heat treatment 
(Y axis is in transmittance). 
DNA analysis 
Some differences existed in total amount of DNA, but overall the two separately performed 
studies showed the same results. The data from the DNA assay of the first study are shown in 
Figure 3 (P<0.05). DNA content remained low till day 3 with no significant difference 
between the four CaP coatings (as-sputtered HA coating, as-sputtered DCPP coating, heated 
HA coating and heated DCPP coating). From day 3 on, DNA content did still not change for 
both amorphous coatings. This in contrast to both heat-treated coatings. For heat-treated HA, 
an increase in DNA can be seen starting at day 5 of incubation. This increase continued till 
day 8. Statistical analysis confirmed the following significant difference: DNA content for 
HA heat-treated at 5 days < DNA content for HA treated at 8 days = DNA content for HA 
treated at 12 days. For heat-treated DCPP coatings an increase of DNA content was seen at 
day 8 and continued till day 12 of incubation. Statistical testing revealed the following 
significant differences (P < 0.05): DNA content heat-treated DCPP at 5 days = DNA content 
heat-treated DCPP at 8 days < DNA content heat-treated DCPP at 12 days. Finally, statistical 
testing also showed that increase of DNA content started earlier on the heat treated HA 
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coatings; DNA content heat treated HA at 8 days > DNA content heat treated DCPP at i· 



















Figure 3: DNA content of the REM cells on all different coating surfaces at the end of the various 
incubation times. Values are mean ± SD. 
A l kal in e phosphatase 
Again no large differences in alkaline phosphatase activity existed for the two separate 
experimental runs. The data of the first study are shown in Figure 4. For both amorphous 
coatings no significant increase in AP expression was seen. This in contrast to the heat-
treated coatings, which showed a continuous increase during incubation. For the heat-treated 
HA coatings this increase becomes significant compared with the preceding incubation times 
at day 8 and for heat-treated DCPP at day 12. In addition, no significant difference in alkaline 












Figure 4 Alkaline phosphatase expression of the RBM cells on all different coating surfaces at the end of 
the various incubation times. Expression was normalized for protein content. Values are mean ± 
SD. 
Osteocalcin 
Overall, no differences existed in osteocalcin expression between the two separate 
experimental runs. The results of the first experimental run are shown in Figure 5. For the 
amorphous coatings, osteocalcin expression was very low for all incubation times and neither 
and increase or decrease occurred during time. For the heat treated DCPP coatings, 
osteocalcin expression appeared to increase starting at day 16 of incubation, but statistical 
testing showed that these differences were not significant compared with 8 and 12 days of 
incubation. On the other hand, osteocalcin expression on the heat treated HA coatings was 
significantly increased compared with 8 and 12 days of incubation. In addition at 16 days of 
incubation, the osteocalcin expression on the heat treated HA coatings was significantly 
higher compared with the heat-treated DCPP coatings. No difference in osteocalcin 
expression on heat treated HA coatings existed between 16 and 24 days of incubation. 
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Figure 5 Osteocalcin expression of the RBM cells on all different coating surfaces at the end of the various 
incubation times. Expression was normalized for protein content. Values are mean ± SD. 
Scanning electron microscopy (SEM) 
SEM confirmed the presence of cells on all four types of CaP coating for all incubation times. 
Nevertheless, clear differences were seen. The number of cells on both amorphous coatings 
was very limited (Figure 6a). Both amorphous coatings showed severe signs of dissolution as 
characterized by the occurrence of many surface pits and cracks. Dissolution of the 
amorphous HA coating could occasionally be associated with the deposition of a precipitate 
(Figure 6b). On the heat-treated coatings, the cells proliferated well and formed a multilayer 
of cells with extensive collage fiber formation and surface mineralization in the form of 
globular accretions (figure 6c). 
Additional EDS measurements showed that the Ca/P ratio of the amorphous HA coating 
decreased to 1.61 ±0.02 at 8 day of incubation and to 1.55 + 0.02 at day 16 of incubation, 
while the Ca/P ratio of amorphous DCPP coating increased to 1.13 + 0.01 at day 8 of 
incubation and 1.32 + 0.01 at day 16 of incubation. The Ca/P ratio of the heat treated DCPP 
coating at 8 days was found to be 1.17±0.01 and at 16 days 1.25+0.02, while the Ca/P ratio 
of the heat treated HA coating decreased somewhat, i.e. 1.95 + 0.05 at day 8 and 1.92 + 0.05 
at day 16. 
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Figure 6: SEM micrographs showing: (A) an amorphous DCPP coating after 8 days of cell culturing, (B) an 
amorphous HA coating after 16 days of cell culturing, (C) an heat treated HA coating after 16 days of cell 
culturing. 
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Discussion and conclusions 
In this study, the growth and differentiation of bone-like cells on magnetron sputtered DCPP 
and HA coatings were compared The coatings were used as prepared or after receiving an 
additional heat treatment Although the Ca/P ratios of the deposited coatings were found to 
deviate from their reported stoichiometnc values, the coatings showed the XRD pattern of 
DCPP respectively HA after heat treatment with infrared radiation [17] Considering the rat 
bone marrow cell behavior, some significant differences were observed On both amorphous 
DCPP and HA coatings, the cells did not proliferate and differentiate at all In contrast, bone 
marrow cells on the crystalline coatings showed an increase in number as well as osteogenic 
expression during culture This increase in proliferation and differentiation started earlier on 
the crystalline HA coatings These results corroborate with our earlier studies dealing with 
the behavior of bone marrow cells on magnetron sputtered CaP coatings [18] 
Different theories have been presented to explain the bioactive characteristics of CaP 
ceramics One hypothesis is that CaP ceramic is bioactive due to dissolution and precipitation 
of calcium and phosphate ions out of the surface layer resulting in the formation of a surface 
layer that resembles the natural bone matrix and stimulates osteogenic differentiation [19] 
Nevertheless, the effect of CaP coating crystallinity and solubility on bone formation has 
been found to differ between different studies For example, some studies indicated that CaP 
ceramics with high solubility induced more bone formation than Ca-P ceramics with a low 
solubility [20-22] In addition, a number of in vitro studies showed that osteogenic 
differentiation of bone cell cultures is higher on amorphous CaP substrates compared to 
crystalline CaP substrates [23] In contrast, other in vitro and in vivo studies reported the 
opposite and observed that the dissolution of CaP ceramic inhibited osteogenic differentiation 
and bone formation [24] A similar observation was done in the current study, which also 
showed an inhibition of cell proliferation and differentiation on the amorphous HA as well as 
DCPP coatings SEM analysis confirmed that the amorphous substrate surfaces showed 
significant dissolution, whereby only for the amorphous HA coatings the dissolution resulted 
in the occasional deposition of a new surface precipitate This difference can be explained by 
the different Ca/P ratios of both coatings The Ca/P ratio of the amorphous DCPP coating is 
about 0 8, resulting in the presence of a lot of H2PO4 in the coating surface, which in addition 
dissolves much easier The dissolution of the amorphous HA coating will result in a decrease 
of the Ca/P ratio, whereby at the same time a precipitate is formed with a lower CaP ratio 
than the onginal amorphous sputtered coating Further, it has to be emphasized that 
dissolution of CaP coatings will result in an increase of interfacial ions [25], which may cause 
apoptosis of osteogenic cells and cause damage to already formed bone [26] Besides ions, 
also Ca-P particles can be released from the material, which again have been shown to inhibit 
osteoblast function in vitro [27] and to cause inflammation and cell death in vivo [28] 
Consequently, the results of this study suggest that amorphous sputtered DCPP and HA 
coatings are not very suitable to support bone healing around medical and dental implants 
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A second hypothesis to explain the bioactive behavior of CaP ceramics deals with the 
preferential adsorption of proteins or even the selective adhesion of specific cell populations 
[29]. Considering the crystalline structure of the heat treated DCPP and HA coatings and the 
resulting limited dissolution, our study appears to support this second hypothesis. The 
increase of alkaline phosphatase and osteocalcin expression during prolonged cultunng 
proves that both crystalline coatings can have a strong influence on the mineralization 
process of heterogenic cell populations, like bone marrow stromal cells. Although, 
extrapolation of in vitro results to the in vivo situation is always complex, the results indicate 
that the osteogenic effect of magnetron sputtered crystalline HA coatings is even better 
compared with the crystalline DCPP coatings, because the level of alkaline phosphatase and 
osteocalcin expression, which is supposed to reflect differences in the degree of 
differentiation in osteoblastic cells, started to increase earlier on the crystalline HA coatings 
[30,31] 
In summary, we conclude that the rat bone marrow stromal cells proliferated and 
differentiated only on crystalline magnetron sputtered DCPP as well as HA coatings. The 
results seem to indicate that the crystalline HA coatings induce even an earlier osteogenic 
effect than the crystalline DCPP coatings. Nevertheless, it has to be emphasized that in vitro 
data are always difficult to extrapolate to the in vivo situation. Still, the current results 
warrant the further in vivo analysis of the bone healing supporting properties of magnetron 
sputtered crystalline DCPP and HA coatings. 
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Introduction 
The calcium phosphate (CaP) ceramic hydroxylapatite (HA) has been used widely for bone 
implantological purposes [1, 2]. In view of this, many investigators have already demonstrated 
that HA coated implants are surrounded by more bone than uncoated ones because of the 
osteoconductive behavior of HA [3-8]. Also, a firm fixation in the bone tissue is obtained by the 
establishment of a chemical bonding at the bone-HA coating interface [9-11]. Till now, HA has 
been considered as the preferred material because it is the end product of the biological 
mineralization process during natural bone formation as well bone healing. On the other hand, 
several intermediate CaP phases can be discerned in the biomineralization process, which 
perhaps are also attractive from an implantological point of view. For example, it can be 
hypothesized that implants made of or provided with such early CaP phase compounds 
participate even more actively in the bone healing process. Hence, use has already been made of 
the minerals brushite (CaHPCVZ^O), tncalcium phosphate (TCP: CasiPO^) and 
octacalciumphosphate (OCP: Ca4H(P04)3 2-5H20). These materials show the remarkable 
property that they are resorbed during time after implantation with a subsequent increase in bone 
tissue formation. In view of this, there is also another precursor to bone apatite to which not 
much attention is paid as bone substitute or implant coating. This mineral phase is calcium 
pyrophosphate (DCPP: Ca2P207), a condensed phosphate which is of biological importance in 
calcium metabolism [14]. In bone, calcium pyrophosphate can regulate the onset of calcification 
and can act as a trigger mechanism to promote mineralization. It can also alter the rate of crystal 
growth and dissolution. In view of this suggested benefit, our current studies focus on the use of 
DCPP as coating material for dental and orthopedic implants. 
Currently, the most applied method to deposit CaP coatings on metallic implants is 
plasma-spraying. However, the retention of the bond between CaP coatings and underlying metal 
surface is an issue of continuous discussion. To avoid this problem, use can be made of other 
coatings techniques, like laser ablation, electrophoretic deposition, sol-gel deposition or sputter 
deposition. For the current study a radio frequent (RF) magnetron sputter method was used to 
deposit DCPP coatings on roughened titanium substrates. The advantage of this method is that 
thin coatings (100 nm -2 μτη thick) can be deposited with very high adhesion strength [15]. 
Besides adhesion, a relevant issue is the maintenance of the coating after implantation and the 
subsequent physicochemical changes that take place in the coatings after implantation. Usually, 
this behavior is investigated in so-called in vitro dissolution studies, where coated samples are 
incubated in simulated body fluid (SBF) and the resorption as well as compositional coating 
changes is determined after various incubation times. Unfortunately, in vitro assays cannot 
completely mimic the in vivo situation [16]. This is confirmed by a study in which Ca-P coated 
specimens were inserted into the back of rabbits [17]. 
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Considering all the above mentioned, we hypothesize that DCPP can undergo readjustment after 
implantation and is a material with biological potential for the coatings of dental and orthopedic 
devices In view of this, the aim of this study is to investigate the in vivo dissolution and 
compositional behavior of DCPP coated titanium discs in a subcutaneous goat model 
Materials and Methods 
Implant preparation 
For the experiments commercially pure titanium (cpTi) disc were provided with various CaP 
sputter coatings The discs measured 1 5 mm in thickness and had a diameter of 12 mm All discs 
were AbOs-blasted on one side (Ra= 1 0-1 3μιτι), which was provided with a 
1 Calcium pyrophosphate- coating with a thickness of 2 μπι (DCPP), or 
2 Hydroxyapatite coating- coating with a thickness of 2 μιη (HA), or 
3 Left uncoated 
RF magnetron sputter coatings were made by using a commercially available RF sputter 
deposition system (Edwards ESM 100) The target materials were calcium pyrophosphate 
(ß-Ca2P207) and hydroxylapatite (CasiPO^sOH) granules (diameter 0 5-1 0mm) The test 
specimens were mounted on a rotating and water-cooled substrate holder The distance between 
target and substrate was 80 mm Before sputtering the metal substrates were cleaned by etching 
for 10 mm with argon ions During deposition, the argon pressure was kept at 5 χ 103 mbar and 
the sputter power was 400W 
After deposition, the coated specimens were subjected to an additional infrared heat treatment 
(HT) for 30 sec at 550 and 650°C (Quad Ellipse Chamber, Model E4-10-P, Research Ine ) 
Before implantation, the coatings were characterized by thin film X-ray diffraction (Philips, 
PW3710, Almelo, The Netherlands), Fourier transform infrared (FTIR, Perkin Elmer, Fremont, 
CA, USA) and a scanning electron microscope (SEM, Jeol 6310, Tokyo, Japan) equipped with 
an energy dispersive spectroscope in order to determine the coating Ca/P ratio 
in vivo subcutaneous study 
Six adult male goats with a mean body weight of about 60 kg were used in this study Before 
surgery blood samples of the goats were taken to ensure that the animals were CAE/CL arthritis 
free The animals were housed in a stable National guidelines for the care and use of laboratory 
animals were observed 
IR heated HA and DCPP coated discs were implanted subcutaneously into the dorsal region of 
the goats The operation was performed under local anesthesia The anesthesia was induced by 
infiltration with 2% lidocain solution To reduce the risk of pen-operative infection, the goats 
were treated according to the following doses of antibiotics 
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• during the operation: Albipen® 15 %, 3 ml/50 kg s.c; 
• one day after the operation: Albipen* LA, 7.5 ml/50 kg s.c; 
• three days after the operation: Albipen®LA, 7.5 ml/50 kg s.c. 
Four implantation periods were used: 1 week, 4 weeks, 8 weeks, and 12 weeks. Paravertebrally, 
on either side of the vertebral column four surgical areas were used as recipient sites (alternately 
the left or right flank and caudal or frontal). The various recipient sites (each recipient site 
represented one implantation time) as well as materials in each recipient area were randomized 
according to a split plot design to exclude the effect of implantation location and individual 
differences. In four surgical sessions, the implants were placed subcutaneously into the back. 
Before surgery, the skin was shaved, washed, and disinfected with iodine. During each surgical 
session, three longitudinal incisions of about 1.5 cm were made parallel to the spinal column in 
the specific recipient site. Lateral to these incisions, small subcutaneous pockets were created by 
blunt dissection with scissors. The implants were inserted into these pockets and the wounds 
closed using Vicryl 3-0 intracutaneously. Each goat received 12 discs, six in the left and six at 
the right side of the spinal column. In total 72 discs were implanted, i.e. 24 infrared heated HA, 
24 infrared heated DCPP coatings and 24 control Ti dies. 
Physicochemical and histological analysis 
At the end of the 12 week period of the experiment, a longitudinal incision was made on both 
sides of the vertebral column. Then, the implants were exposed and retrieved including their 
surrounding fibrous tissue capsule. After removal, the implants were stored in alcohol water and 
transported to the laboratory. Subsequently, half of the retrieved specimens were used for 
physicochemical characterization and half for histological analysis. 
For physicochemical characterization of the coatings after implantation, discs were removed out 
of the surrounding fibrous tissue capsule. The characterization consisted of thin film X-ray 
diffraction and scanning electron microscopy including energy dispersive spectroscopy. 
For the histological observation, the specimens were fixed in formaldehyde 4%, dehydrated in 
serial ethanol solutions and embedded in methylmethacrylate (MMA). After polymerization in 
MMA thin (10 μπι) non-decalcified sections were prepared with the Leiden-Microtome Cutting 
System (Biomaterial Research Group, Leiden University, The Netherlands), stained with basic 
fuchsin and methylene blue, and studied with a light microscope. Photomicrographs were taken 
of the tissue-implant interfaces for each histological section. At least two histological sections 
were evaluated of each material. 
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Results 
Implant surface characterization before implantation 
X-ray diffraction 
The XRD patterns of the as-sputtered coatings showed an amorphous structure with no clear 
peaks (Figure 1). Infrared heat-treatment at 550oC changed the amorphous sputtered HA 
coatings into a crystalline apatite structure with reflections 002, 211, 112, 202, resp. 25.9°, 31.9°, 
32.4° and 34.0° in 2-Theta, comparative with the XRD pattern of HA powder (JCPDS #09-0432). 
In contrast, the sputtered amorphous pyrophosphate coating required an annealing temperature of 
650oC to alter into crystalline beta-calcium pyrophosphate structure with reflections lines 201, 
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Figure 1: XRD patterns of the sputtered CaP coatings. The numbers indicate the major reflection lines for HA 
and dicalcium pyrophosphate. (A: apatite, P: pyrophosphate and S: titanium substrate) 
Fourier transform infrared spectroscopy 
FT1R measurements showed for all the amorphous coatings two clusters of bands from 900-1150 
and from 550-600 cm"' attributed to the major absorption modes associated with the presence of 
phosphate (Figure 2). Heat treatment of the amorphous HA coatings resulted in the appearance 
of the hydroxy! band at 630 cm" , characteristic for hydroxylapatite and the appearance of 
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various P-0 bands at a wavelength of 587, 630, 965, 1009, 1083 cm"1 (Figure 2). Heat treatment 
of the sputtered amorphous pyrophosphate coatings resulted in the appearance of various P-0 
bonds at the wavelength around 1202, 1163,1125, 1095, 1081, 993, 957, 644, 608, and 522 cm', 
which are characteristic for the beta-calcium pyrophosphate structure (Figure 2). 
1500 lOOO 4SOfi 
<m-l 
Figure 2: FTIR spectra of the various CaP coatings before and after infrared heat treatment 
(Y axis is in transmittance). 
Scanning electron microscopy 
SEM examination of the sputtered coatings showed an excellent coverage of the substrate 
surface. Heat treatment was found to have no evident effect on the HA as well as pyrophosphate 
coating morphology (Figure3). 
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Figure 3 SEM pictures ofRF sputtered HA and DCPP coatings after infrared heat treatment; A = IR heated HA 
coating, Β = IR heated calcium pyrophosphate coating. 
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Energy dispersive spectroscopy 
EDS analysis revealed that Ca/P ratio of amorphous as well as crystalline HA- and DCPP 
coatings varied between respectively 1.9-2.0 and 0.76-0.8. 
In vivo evaluation 
Coating surface changes measured by XRD 
Figure 4 and 5 show the XRD patterns of the sputtered coating surfaces after 2, 4, 8 and 12 
weeks implantation in the goat. The peaks around 25.9°, 26.6°, 31-33° in the XRD of infrared 
heated HA coatings showed a very limited decrease during the 12 weeks implantation time, 
which indicates a stable behavior of these coatings during implantation in an in vivo environment 
In contrast, the XRD patterns of the infrared heated DCPP coated discs showed significant 
changes during implantation. Additional peaks appeared and some peaks intensified around 
25.9° and 31°-330, which indicates the formation of an apatite and TCP precipitate on the coated 
surface. Especially, the appearance of TCP and apatite peaks corresponding to 25.9°, 31°, 31.9°, 
32.4° and 34.5° and the decrease of peak intensity around 29.7° for the 12 week specimens 
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Figures XRD patterns of infrared heated DCPP coating after implantation for 2 weeks to 12 weeks in the 
goats. 
Coating surface changes measured by SEM and EDS analysis 
Scanning electron microscopic (SEM) evaluation revealed that the removal of the implants out of 
their surrounding capsule had still left in the maintenance of some tissue debris. The implants 
were locally still covered by a tenacious layer of collagen fibers (Figure 6A). Nevertheless, this 
did not prevent a proper analysis. As demonstrated by SEM, after 12 weeks of implantation both 
the infrared heat-treated HA and DCPP coatings were maintained (Figure 6B and 6C). This was 
confirmed by EDS analysis (Table 1). EDS examination revealed that the Ca/P ratio of the DCPP 
coatings changed from 0.8 to 1.52, while the Ca/P ratio of the HA coatings remained stable 
during the 12 weeks of implantation. 


























Ι Β Ι 
Λ 
me* 
b ì o m a t . 1 β Κ U 
— -* „„si-
^ % 
t β H m 
^ 2 ^ Θ Θ Θ I S r n m . 
Figure 6 SEM photographs of HA and DCPP coating surface after subcutaneous implantation: A = HA coating 
after 2 weeks of implantation, Β = HA coatings after 12 weeks of implantation and C = DCPP 
coatings after 12 weeks of implantation. 
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Histological analysis 
Light microscopical evaluation of the specimens retrieved for histological analysis showed a 
biocompatible tissue behavior of both coatings and non-coated control specimens at all 
implantation times. Already at two weeks of implantation, both the heat-treated HA, DCPP 
coated and control Ti discs were surrounded by a thin (10-20 cells thick) fibrous tissue capsule 
(Figure 7A). During time, the capsule became denser, but did not increase in thickness. The 
capsular tissue was almost completely free of inflammatory cells. At the interface, a close 
contact existed between the fibrous capsule and the coating surfaces. In general, the interfacial 
response at al implantation times was characterized by the absence of inflammatory cells (Figure 
7B). 
Figure 7 Light micrographs of histological sections of HA and DCPP coated discs after subcutaneous 
implantation: A = DCPP coated disc; already two weeks after implantation, the disc is surrounded by 
a thin fibrous capsule that is in close contact with the coated surface (original magnification = 400x), 
Β = HA coated disc; 12 weeks after implantation the fibrous capsule has densified and inflammatory 
cells are absent at the capsule-coating interface (original magnification = 400x). 
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Discussion and Conclusion 
The aim of the current study was to leam more about the dissolution and compositional behavior 
of thin heat-treated HA and DCPP coatings under in vivo conditions Evidently, the results 
confirmed again the effectivity of our model for this kind of analyses The heat-treated HA 
coatings were found to be stable during 12 week implantation in the subcutaneous tissue of goats 
No structural or compositional changes were observed This in contrast to the heat-treated DCPP 
coatings, which changed during time into apatite and TCP, which could be linked with a change 
in Ca/P ratio from 0 8 to 1 52 Further, both coatings were observed to evoke a biocompatible 
behavior charactenzed by the lack of a senous inflammatory response Referring to implantation 
studies with plasma-sprayed TCP coatings [18] where during the initial weeks of implantation a 
significant increase in the number of inflammatory cells was seen, this suggests that the 
conformational change of the DCPP coatings is related to a gradual increase in the local 
concentration of calcium and phosphorus due to surface dissolution and precipitation However, 
we have to emphasize that more research is required to the associated coating surface phenomena 
to support this suggestion Further for the in vivo coating characterization, no use was made of 
FTIR This was done, because the coatings were found to be coated with a very persistent 
organic layer, consisting amongst others of NH2-groups, which prevented a proper analysis of 
the coatings SEM examination confirmed the presence of this organic layer that also could not 
be removed without senous damage to the coated film 
The X-ray diffractograms and EDS measurements revealed a gradual conformational change of 
the DCPP coatings into apatite and TCP in the subcutaneous tissue This corroborates with the 
existing theory about the stability of calcium phosphate salts in a biological environment [19] 
Under physiological conditions, calcium phosphate compounds are in a state of equilibrium with 
the formation of hydroxylapatite as the preferred, most stable phase This is also the reason that 
all calcium phosphate ceramics are considered to be biocompatible besides the occurrence of 
differences in solubility and dissolution rate into biological fluids The resistance against 
dissolution can further be affected by thermal post-treatment For example, transforming 
amorphous HA coatings thermally into a more stable phase, is a standard procedure to avoid fast 
coating degradation [20] A similar observation was done in the current study, rapid infrared 
radiation appeared to be an effective way to improve the crystallinity of the deposited coatings 
Consequently, the peaks in the XRD pattern of the HA coatings showed a very limited, but still 
gradual decrease during the 12 week implantation time This indicates that bioadsorption of the 
coating is possible, but only at a very low dissolution rate A similar finding was done in an 
earlier subcutaneous study to the dissolution behavior of sputtered CaP coatings in rabbits [17, 
21] Then, a 0 1 μιτι thick heat-treated HA coating deposited on roughened titanium discs was 
found to degrade completely within 8 weeks of implantation, while 1 and 4 μιτι thick coatings 
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were maintained till 12 weeks of implantation It can be assumed that finally the same will 
happen with the heat-treated DCPP coatings, ι e during the transformation of the DCPP in 
apatite and TCP dissolution will occur resulting at the end in complete loss of the coating Of 
course in a bony environment, at the same time an interfacial bonding zone will develop between 
the implant surface and surrounding bone [22, 23] 
Considering the above mentioned, the reason for the choice of an in vivo test was that the 
dissolution behavior of CaP biomatenals implanted in vivo can be completely different 
compared with classical in vitro tests This is due to the fact that the in vivo environment is 
composed of a complex array of various constituents, in particular macromolecules, which can 
all interact with CaP compounds Such a condition can never be completely copied in an in vitro 
model In view of this, it is even possible that CaP coated implants show different behavior in 
different tissues, like bone, muscle and subcutaneous tissue For example, it is well know that all 
these tissues differ in composition and complexity and that difference in concentrations and 
availability of proteins, relevant for the dissolution and subsequent bonding zone development, 
occurs [24] 
The light microscopical evaluation confirmed also the biocompatibility of both the HA and 
DCPP coatings The interfacial response was characterized by a close contact between the 
fibrous capsule and coated implant surface with hardly any inflammatory response The capsule 
is the consequence of the surgical trauma and the subsequent installation of foreign body 
Nevertheless, the interfacial response is much better compared to a lot of polymeric implant 
materials Evidently, this is caused by the biocompatible behavior of both titanium and CaP 
materials In addition, a very limited surface roughness seems to have no additional negative 
effect on the final tissue response, which agrees with a previous study [21] It can be supposed 
that movement in the flank of a goat is still very restricted or that the very confined surface 
roughness results in an improved subcutaneous anchorage of the coated discs, which can explain 
why the surface roughness did not result in an increase of inflammatory cells 
Our final goal is to use the DCPP coatings for bone implants Currently, only very limited 
information is available, which indicates that both in vitro and in vivo, synthetic dicalcium 
pyrophosphate supports bone tissue formation [13, 25, 26] In a recent in vitro study, we also 
observed that DCPP coatings are able to increase the proliferation and differentiation of 
osteoblast-like cells [27] However, the mechanism of the underlying process and the exact 
benefit of DCPP coatings have to be proven Further, care has to be taken of the fact that the 
precise structure of synthetic CaP compounds can differ vary considerably of the natural material 
[28] Starting material and processing route are very important parameters for the finally 
prepared product How this interferes with the aimed tissue response is yet unclear 
On basis of the results, we conclude that 2 μπι thick infrared heat-treated, RF magnetron 
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sputtered HA and DCPP coatings are of sufficient thickness to withstand dissolution during 12 
weeks of implantation in a subcutaneous location in goats. In addition, both coatings showed a 
biocompatible tissue behavior characterized by the formation of a thin fibrous tissue capsule and 
the absence of an inflammatory response. Further, infrared heat-treated DCPP coatings revealed 
a gradual compositional change into apatite and TCP. Of course, the conclusive beneficial effect 
of DCPP coatings has to be proven in a bone implantation study. 
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Introduction 
Hydrothermally synthesized, nanograde, needle-shaped apatite crystal (nanoapatite) is similar 
to bone apatite in morphology, crystal structure, composition and crystallinity, and could 
probably improve biological performance of calcium phosphate biomaterials [1-4]. But most 
calcium phosphate ceramics are brittle and fracture easily when used for load bearing 
implants. In order to enhance the toughness of calcium phosphate biomaterials, this ceramic 
is applied as coating on mechanical strong titanium implant materials [5-7]. There are many 
ways to make this kind of coatings of which plasma spraying is nowadays the most widely 
used technique to apply such coatings [8, 9]. However, this method suffers from some severe 
drawbacks (such as a limited adherence to the substrate, the large thickness of the coating and 
the non-thickness uniformity) [10]. Another limitation of plasma spraying is the high 
temperature that may decompose or destroy polymers, so that it cannot be applied to deposit 
CaP coatings on polymeric biomaterials. Therefore other techniques to prepare thin, strong 
and dense coatings have been investigated [10-16]. Among these techniques RF magnetron 
sputter deposition is a promising way to get a thin, adherent, and dense calcium phosphate 
coatings and can also be used for the coating of polymers [17-21]. 
Another way to avoid the brittle poor property of CaP bioceramic is to make HA/polymer 
composites. The combination of bioactive HA and tough polymer may result in a new 
load-beanng bioactive material with good mechanical and biological properties [18-25]. At 
present, most HA/Polymer composites are prepared through mixing HA powder and 
polymers and their subsequent extrusion, which makes it difficult to make composites with 
good homogeneity and high bioactivity. Preparation of apatite/polymer composites in 
solution and co-polymerization would be more helpful than mechanically mixing with 
clogged powders [26-29]. Since the HA component in the composite is usually lower than 
50% in weight (when the HA content is HA too high, the composite becomes brittle) [30, 31], 
the composite may not be as bioactive as pure HA. To develop more bioactive and strong 
biomaterials, we suggest to deposit a HA coating on the polymer and the HA/polymer 
composite surface in order to improve the bioactivity of these materials similar to what is 
done on the surface of metals 
Therefore, the objective of this study is to deposit thin HA films on the surfaces of 
polyamide-6 (PA6) and nano-HA /PA-6 composite (NHA/PA-6) using a RF magnetron 
sputter deposition method in order to obtain biomaterials with increased bioactivity. 
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Materials and Methods 
Target materials 
Hydroxyapatite (HA) granules were used as target material. Further, Polyamide-6 (PA-6) 
with a molecular weight of 18000 (weight average molecular mass) (Asahi Chemical Co. Ltd, 
Japan) was used. 
Nanohydroxyapatite/Polyamide-6 composite (NHA/PA-6) was prepared by a solution 
approach as described before [21-22]. The nano-HA in the composite was about 40 wt%. 
Substrates for coating deposition were prepared by injecting PA-6 at 250oC and 
nanohydroxyapatite/PA-6 composites at 2650C respectively through an extruder and then cut 
to 10x1 Ox 1mm discs. 
Sputtering 
RF magnetron sputter coating was performed using a commercially available RF sputter 
deposition system (Edwards ESM 100). The target material was HA. The substrates, PA-6 
and NHA/PA-6, were attached to a water-cooled specimen holder using silver-paint. The 
specimen holder was continuously rotated. The process pressure was 5 xl0"3mbar, the sputter 
power was 300w and the sputter time was 6 hours, resulting in a coating with a thickness of 
about 2 μιη. Subsequently, a part of the sputtered samples was heated at 140oC in water 
steam for 6 hours. 
Coating characterization 
The crystallographic structure of the deposited HA films and precipitates on the coating 
surface were determined by thin film X-ray diffraction (XRD) using a Philips X-Ray 
Diffractometer (PW3710), using CuKa-radiation. The infrared spectra of the films on the 
substrates were obtained by reflection Fourier transmission infrared spectroscopy (FTIR) 
(Perkin-Elmer 850). The appearance and the uniformity of the coating were examined with a 
scanning electron microscope (Philips SEM-525) with an energy disperse spectroscopy 
(EDS) x-ray detector. Information about the elemental compositions of the coated specimens 
was obtained by both EDS analysis and X-ray probe scanning (XPS, XSAM 800). Atomic 




Changes in the structure of the PA-6 and NHA/PA-6 composite surface 
Figure la shows the IR spectra of PA-6, sputtered PA-6, and sputtered PA-6 after heat 
treatment at 140oC in water steam. Figure lb shows the IR spectra of NHA/PA-6 and its 
sputtered samples, respectively. The peak at 3301 cm"1 in PA-6 and in NHA/PA-6 composite 
belongs to the N-H bond. The stretching vibration of N-H and C=0 in PA-6 could be 
observed at 3423cm"'and 1641 cm"' in both PA-6 and NHA/PA-6 composite. Comparison of 
IR spectra of original PA-6 and NHA/PA-6 composite with those of sputtered samples 
revealed that the peaks at 3301 cm"1 and 3423cm"1 disappeared in both PA-6 and NHA/PA-6 
composite, while the peaks around 1641 cm"' became very weak for both PA-6 and its nano 
HA composite after sputtering. A broad big peak around 1000 cm" was present for the 
sputtered PA-6 sample and the peaks around 1000 cm' in NHA/PA-6 became rounded. After 
heating at 140°C in water steam, the peaks around 1000 cm' became sharp and did split. 
Also, a peak at 630 cm"' became stronger after heating at 140oC in water steam, indicating 
that the amorphous HA coating changed into a crystalline structure. 
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Figure 1: FTIR spectra of PA-6 and NHA/PA-6 composite before and after sputtering (A) PA-6 and (B) 
ΝΗΑ/ΡΑ-6 
Ca, Ρ and Ο binding energy changes in the NHA/PA-6 composite surface 
Table 1 lists the binding energy of the Ca, Ρ and Ο in original HA (hydroxyapatite powder), 
PA-6, NHA/PA-6 composite, sputtered samples and sputtered samples heated at 140°C in 
water steam. The results show that the binding energy of Ca, Ρ and Ο differs before and after 
sputtering. The binding energy of Ο in NHA/PA-6 composite was 531.8 ev, higher than that 
of Ο in original HA with 0.3 ev; the binding energies of Ca in NHA/PA-6 composite were 
351.5 and 347.6, also higher than those of the original HA with 0.6 and 0.2 ev. The binding 
energy of Ρ was also 0.1 ev higher than the original binding energy. These findings can be 
explained by the affinity between Ca2+, hydroxyl (-OH), PO43' in apatite and carboxyl 
(-COOH) in the copolymer. In view of this, there appears to be some combination between 
HA and Poly amide-6, indicating that the composite has a stable interface. 
Comparison of the binding energy of Ca, Ο, and Ρ in sputtered PA-6, sputtered NHA/PA-6 
composite and heated samples in water steam with those of the original HA showed that the 
binding energy of Ca, Ο, and Ρ in sputtered PA-6 and sputtered NHA/PA-6 composite was 
very close to those in original HA. This means that the coating kept the HA properties after 
sputtering and after heated at 140°C in water steam. 
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Changes in surface composition of PA-6 and NHA/PA-6 composite 
Figure 2 shows the XRD patterns of PA-6, sputtered PA-6, and sputtered PA-6 after heat 
treatment at 140oC in water steam. Figure 3 depicts the XRD patterns of NHA/PA-6 
composite and its sputtered samples, respectively. The peaks at 21° and 23.5° in 2Θ can be 
assigned to the PA-6 substrate. These peaks show no big changes in the XRD before and after 
sputtering of both PA-6 and NHA/PA-6 composite. After heating of the sputter coated PA-6 
samples at 140oC in water steam, peaks at 25.9°, 31.9°, 32.4° and 34.0° 2Θ appeared 
(reflections 002, 211, 112, 202), indicating HA crystal formation on the PA-6 surface. A 
similar phenomenon occurred at the NHA/PA-6 composite specimens. Evidently, after 
heating the sputtered coatings showed the same typical HA crystal structure as the XRD 
patterns of HA coatings on a titanium surface after heat treatment [16]. 
PA-6 
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Figure 2 XRD patterns of PA-6, sputtered PA-6 and sputtered PA-6 heated at 140oC in water steam 
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Figure 3: XRD patterns of NHA/PA-6 composite, sputtered NHA/PA-6 and sputtered NHA/PA-6 heated at 
140oC in water steam 
Ca-P content and Ca/P ratio changes of the PA-6 surface and NHA/PA6 composite surface 
Table 2 shows the Ca/P ratio and HA content on the surface of the PA-6 and NHA/PA-6 
composite before and after sputtering as measured by EDS. These figures show that little Ca 
and Ρ were present on the original PA-6 surface. The Ca and Ρ content on the original 
NHA/PA-6 composite surface was 25.78 % and 11.27 %, respectively. After sputtering, the 
Ca and Ρ content on the surface of PA-6 increased to 42.55 % and 17.66 %, and for the 
NHA/PA-6 composite to 3l.l0a% and 14.61 % respectively. After heating at 140oC in water 
steam, the Ca and Ρ content changed very little. The Ca/P ratio of the as-prepared NHA/PA-6 
composite surface was 1.77 and decreased after sputtering to 1.64. The Ca/P ratios of the 
coated specimens changed very limited after heating at 140°C in water steam, indicating that 
the original composition and properties of both polymers were maintained. 
Morphology of the surface of the coated PA-6 and NHA/PA-6 composites 
Figure 4 shows the SEM micrographs of PA-6, sputtered PA-6, and sputtered PA-6 after heat 
treatment at 140oC in water steam. Figure 4 shows also the SEM pictures of NHA/PA-6 
composite and its sputtered samples. The results show that after sputtering the surfaces of 
both PA-6 and NHA/PA-6 composite were covered with dense HA films. The HA film 
looked homogenous. After heating at 140oC in water steam a uniform layer of crystals was 
formed, this covered the surfaces of both PA-6 and NHA/PA-6 composites. Figure 5 depicts 
the AFM macrographs of the uncoated NHA/PA-6 composite, sputtered NHA/PA-6 
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composite and sputtered sample after heating 140oC in water steam A lot of small particles 
covered the original composite surface (Figure 5a) Additional small particles appeared on 
the surface after sputtering and the surface looked blurred because of the amorphous coating 
deposition (Figure 5b) After heat treatment the crystals became clearly visible (Figure 5c) 
The diameter of the particles was about 30-50 nm and their length was about 50~70nm This 
indicated that the HA crystals in the coating had the same morphology as those in the original 
composite, ι e they maintained their nanograde character 
Table 2 Calcium and Phosphate content and Ca/P ratio on the surface of PA-6 and 
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Figure 6: SEM macrograph of PA-6/HA compsite surface after RF sputtering, (a) PA-6 surface, (b) sputttered 
PA-6, (c) sputtered PA-6 heated at 140oC in water steam, (d) NHA/PA-6 composite, (e) sputtered NHA/PA-6 
composite and (f) sputtered NHA/PA-6 composite heated at 140°C in water steam 
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Figure 5: AFM micrograph of (A) NHA/PA-6 composite, (B) NHA/PA-6/HA composite after sputtering an 
(C) NHA/PA-6/HA composite after a steam heattreatment. 
Discussion 
After implantation in the bone, implants directly contact with the body fluid. Precipitation, 
dissolution and exchange of ions occur immediately on the surface of the implants. The 
bioactivity of an implanted material is determined by the surface composition and activity of 
osteoblast-like cells is dependent on the crystallinity and phase composition of the 
CaP-coated surfaces [23, 24]. Although PA is used as medical device, like for sutures, it is 
not bioactive. On the other hand, nano HA/ΡΑ showed a good bioactivity and 
biocompatibility, but it becomes brittle when the HA content in the composite is too high [30, 
31]. Consequently, the deposition of an additional HA coating on the PA and PA composite 
surface can provide bioactivity, while the mechanical properties of the polymers are 
maintained. 
In the present research, we applied the RF magnetron sputter deposition technique to modify 
the surfaces of the PA-6 and NHA/PA-6 composite. The obtained results were found to be 
promising. Usually CaP coatings deposited on the substrates are amorphous or contain 
amorphous phases and need post annealing to get improved crystallinity. The crystallization 
of amorphous Ca-P coating can occur only above a certain temperature (i.e. 500°C) [25]. 
However, heat treatment at a high temperature destroys the polymer. Therefore, a lower heat 
treatment temperature is essential for HA coatings on polymers. Hontsu et al [26, 27] 
investigated the crystallization of CaP coatings on polymeric substrates (PTFE, PI, PDMS, 
and PET) by performing a long anneal (10 hours) just below the melting temperature of the 
substrates. On PTFE and PI, partially crystalline coatings were obtained by annealing at 
320oC and 360°C, respectively. However, on PDMS and PET, the coating remained 
amorphous, after an annealing at 240oC and 260oC. Evidently, decreasing the heat treatment 
temperature is very important for CaP coatings on polymeric substrates. In the current study, 
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we used steam heating to change the crystallinity of amorphous HA coatings on PA-6 and 
NHA/PA-6 composite surface at a low temperature of 140oC. The FTIR peaks at 3301 cm"1 
and 3423 cm"' disappeared in both PA-6 and NHA/PA-6 composite after sputtering, which 
confirmed the deposition of HA on both PA-6 and NHA/PA-6 composite surface. The peak 
around 1000 cm"1 (PO group) was split up after heat treatment at 140°C in water steam on 
both PA-6 and NHA/PA-6 composite surfaces. The XRD patterns indicated that the HA 
coatings on both substrates were amorphous and turned into a crystalline phase after heating 
at 140oC in water steam. Comparison of XRD curve of before and after sputtering showed 
that the PA-6 and NHA/PA-6 material maintained the original crystal structure. 
Besides, it is generally supposed that an amorphous coating dissolves faster than a crystalline 
coating, i.e. crystallinity is the dominant factor for the dissolution of the HA coating. 
However, it has to be noticed that also some studies found little difference in dissolution 
between amorphous and crystalline coatings or even opposite results were obtained [28]. 
Further, the Ca and Ρ content measurements and the Ca/P ratio changes indicated that the HA 
content on the NHA/PA-6 surfaces was much higher than in the NHA/PA-6 composite, 
because the HA content in the substrates decreased from the surface to the inside till a stable 
level was reached. From this point of the view, the coated NHA/PA-6 composite can be 
considered as a gradient bioactive biomaterial. 
The SEM and AFM pictures illustrated that the coating was homogenously deposited and that 
the size of the HA crystals was less than 50 nm. Consequently, the sputtered HA coatings on 
the NHA/PA-6 are a type of nano-HA coatings. This is similar as natural bone, which also 
can be considered as nano-apatitic [29]. Natural bone is an organic-inorganic hybrid material 
made of organic collagen and inorganic apatite crystals with a characteristic structure that 
leads to specific mechanical properties, such as a high fatigue toughness and high flexibility 
[30]. In view of this, the nano-HA coating-nano-HA/PA-6 composite system developed in the 
present study imitates the bone structure. Therefore, the nano-HA coating-PA-6 and nano-HA 
coating-NHA/PA-6 composite system as prepared by RF sputtering might be suitable for 
clinical application as potential bone replacement material and bone fixation material. 
Conclusions 
A new kind of inorganic-organic biomaterials (HA thin film-PA-6 and HA 
coating-nano-HA/Polyamide-6 composite) were successfully developed using RF magnetron 
sputtering. 
Sputtered HA coatings on both the PA-6 and nano-HA/PA-6 composite are homogenous and 
amorphous. The amorphous HA film can change into a fine crystalline structure when heated 
at 140oC in water steam. The crystal structure of the sputtered HA coatings on both PA-6 and 
NHA/PA-6 composite shows a typical HA structure. Therefore, water steam heat treatment is 
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a promising method to alter amorphous HA into crystalline on the polymer surface 
The binding energy of Ca, Ρ and Ο of HA in the HA coating on the composites surface was 
more like that of the original HA powder The diameter of the HA particles in the deposited 
coating was about 40nm The Ca/P ratio was 1 64 after RF sputtering, close to that of the 
stoichiometric HA, but different compared with the HA particles in the original composites 
The prepared inorganic-orgamc and inorganic-organic/inorganic composites show a structure 
similar to natural bone and can have a promising potential for use as bone implant and as 
scaffold material in tissue engineering 
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Summary and final remarks 
Summary and final remarks 
Considering the chemical composition, structure, and response to the biological environment, 
calcium phosphate ceramics have been proven to show an outstanding behavior in orthopedic 
and dental applications, especially for the healing of bone defects and replacement of lost 
teeth as well as damaged joints CaP ceramics provide a more rapid fixation and stronger 
bonding with the host bone as well as increased uniform bone in-growth and/or on-growth 
On the other hand, they revealed apparent limitations in the load bearing bone repair and 
fixation, because of their brittle and easily fatigue nature Therefore, our research was 
focused on a coating technology to develop CaP coatings on mechanically strong metallic 
substrates In our studies, we used mainly titanium as substrate material because of its tissue 
biocompatible and mechanical properties 
Calcium phosphate ceramics are materials that contain Ca and Ρ However, they can vary in 
chemical composition, structure, crystallinity and morphological state Further, they can alter 
into each other under specific physico-chemical or biological conditions Also, the 
manufacturing methods can affect the final properties of the prepared CaP compound 
Usually, most CaP materials are considered to be biocompatible and to support bone 
formation, except monocalcium phosphate (MCP, Ca (H2P04)2), which is too acidic to 
support the cell growth HA is considered to be the end product of bone formation and 
thereby the main ingredient of mature bone However, other CaP ceramics, like CHA 
(carbonated hydroxyapatite), DCPP (dicalcium pyrophosphate) and OCP (octa calcium 
phosphate) are also involved in the biological process of bone formation During the 
development of HA, degradation and transformation of the various CaP phases occurs To 
leam more about this process, we focused for our studies on the behavior of DCPP and HA 
As post heat treatments have a strong influence on the properties of a CaP ceramic, like the 
crystallinity, phase composition and morphology, and even controls their final response in the 
biological environment of these materials, we used different post heat treatments in order to 
obtain RF magnetron sputtered CaP coatings with different characteristics 
So, m the chapter 1 we give a general review of the background about bone, calcium 
phosphate ceramics, coatings, heat treatment, surface characteristic and biocompatibihty 
In chapter 2, calcium pyrophosphate and hydroxylapatite coatings were successfully 
prepared by RF magnetron sputtering deposition The results showed that all the sputtered 
coatings were amorphous and changed into a crystal structure after IR-radiation The 
temperature for the crystallisation of the amorphous coatings is lower for the hydroxylapatite 
coating (550oC), as compared to the calcium pyrophosphate coating (650oC) All sputtered 
amorphous coatings were instable in SBF and dissolved partially within 4 of incubation The 
heat-treated coatings appeared to be stable after incubation These results showed that 
magnetron sputtering of calcium pyrophosphate coating is a promising method for forming a 
biocompatible ceramic coating 
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To improve the properties and to control the composition of the CaP coatings and thereby to 
get the most favourable biocompatible and variable response, Ca-P coatings with different 
Ca/P ratio and composition were successfully prepared by RF magnetron sputtering 
deposition. 
In chapter 3 the production of mixtures of hydroxylapatite and calcium pyrophosphate 
coatings on titanium substrates were investigated. All the as-sputtered coatings were 
amorphous and after IR-irradiation the coatings altered into a crystalline phase. The 
crystallization temperature of amorphous pyrophosphate coating is higher as compared to 
amorphous hydroxylapatite coating. The obtained coatings had a Ca/P ratio that varied from 
0.55 to 2.10 and different phase compositions or mixtures of apatite, beta-pyrophosphate and 
beta-tricalciumphosphate structures were formed. Evidently, the phase compositions of the 
sputtered coatings are determined not only by the discharge power ratio of the 
hydroxylapatite and dicalcium pyrophosphate targets but also by the annealing temperature. 
Post heat treatment at 750oC resulted in an increase of thickness of the TÌO2 layer. 
In chapter 4, the different post heat treatment methods were compared. These surfaces were 
left as-prepared (amorphous HA coating; Α-HA, amorphous dicalcium pyrophosphate coating; 
A-DCPP) or heat-treated with: infrared at 550CC (I-HA) or at 650oC (I-DCPP), and water 
steam at 140oC (S-HA and S-DCPP). The results showed that all the sputtered coatings were 
amorphous and both infrared and water steam heat treatment changed the amorphous phase 
into the crystalline phase. All the sputtered amorphous coatings were instable in SBF and 
dissolved almost completely within 4 weeks of incubation. In contrast, the heat-treated 
coatings appeared to be present after incubation, resulting in the formation of a carbonated 
apatite precipitate on both I-HA and S-HA coating surface, while on the I-DCPP and S-DCPP 
coatings a TCP phase was formed. 
The Ca/P ratio of the Α-HA, I-HA, S-HA, A-DCPP, I-DCPP and S-DCPP coatings changed 
respectively from 1.98-1.12, 2.01-1.76, 1.91-1.68, 0.76-1.23, 0.76-1.26 and 1.62-1.55 after 4 
weeks of incubation in SBF. 
No matter how preferable the materials are in the physico-chemical properties and in the SBF, 
the final evaluation of the materials has to be occur in the biological environment. 
Consequently, the aim of the study in chapter 5 was to evaluate the osteogenic properties of 
magnetron sputtered dicalcium pyrophasphate (DCPP) and hydroxylapatite (HA) coatings. 
Therefore, DCPP and HA coatings were deposited on grit-blasted titanium discs. Results 
demonstrated that the cells did not proliferate and differentiate on all amorphous coatings. 
SEM revealed that the amorphous coatings showed significant dissolution. On the crystalline 
DCPP and HA coatings an increase in DNA and alkaline phosphatase activity was seen 
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starting at day 8 of incubation Osteocalcin expression on the crystalline coatings started to 
increase at day 16 of incubation SEM showed that the growth and differentiation of the cells 
was associated with extensive collage fiber formation and surface mineralization in the form 
of globular accretions Further, statistical analysis of the obtained data revealed that 
proliferation and differentiation of the rat bone marrow stromal cells started significantly 
earlier on the crystalline HA coatings than on the crystalline DCPP coatings These results 
demonstrate that the rat bone marrow stromal cells proliferated and differentiated only on 
crystalline magnetron sputtered DCPP as well as HA coatings, which warrants the further in 
vivo analysis of the bone healing supporting properties of these coatings 
In chapter 6 the in vivo behavior of infrared heated RF magnetron sputtered hydroxylapatite 
(HA) and calcium pyrophosphate (DCPP) coated titanium discs was investigated The coated 
discs were implanted subcutaneously in the back of six goats for 2, 4, 8 and 12 weeks The 
result showed that the heat-treated HA coatings showed a stable behavior, ι e no changes in 
the XRD pattern were observed during implantation Also, no dissolution of the coating was 
observed by SEM EDS revealed that the Ca/P ratio of the HA coatings remained stable 
during the 12 weeks of implantation On the other hand, the heat-treated DCPP coatings 
showed a compositional change into apatite and tncalcium phosphate (TCP) during 
implantation This was confirmed by the SEM and EDS analysis The Ca/P ratio of the DCPP 
coatings changed from 0 8 to 1 52 after 12 weeks of incubation Finally, light microscopical 
analysis showed that both the heat-treated HA and DCPP coatings showed no adverse tissue 
response All discs became surrounded during time by a thin, dense fibrous tissue capsule 
with the very sparse presence of inflammatory cells On basis of these observations, it can be 
concluded that 2 μπι thick infrared heat-treated, RF magnetron sputtered HA and DCPP 
coatings are of sufficient thickness to withstand dissolution during 12 weeks of implantation 
in a subcutaneous location in goats In addition, both coatings showed a biocompatible tissue 
behavior charactenzed by the formation of a thin fibrous tissue capsule and the absence of an 
inflammatory response Further, infrared heat-treated DCPP coatings revealed a gradual 
compositional change into apatite and TCP 
To enlarge the application of RF magnetron sputtering method and steam heating heat 
treatment, we applied this system to the polymer surface In chapter 7 HA ceramics were 
developed as coatings on the surfaces of both the PA-6 and nano-HA/PA-6 composite by RF 
magnetron sputtering The results showed that a thin homogenous amorphous dense HA 
coating formed on the surface of both the PA-6 and nano-HA/PA-6 composite after sputtenng, 
and turned into fine crystal when heated at 140°C 0 4MPa in water steam The Ca, Ρ contents 
on the surface of both the polyamide-6 and nano-HA/polyamide-6 composite strongly 
increased after sputtenng, to 42 55wt%, 17 66wt% and 37 70wt%(25 78), 20 93wt%(ll 27), 
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respectively The Ca/P ratio was 1 86 after RF sputtering, different from that of in the 
NHA/PA-6 composites, 1 77 The crystal structure of the sputtered coatings on both PA-6 and 
NHA/PA-6 composite had a typical HA structure The micrographs showed the HA coating 
consisted of small particles on nano-grade with the diameter about 40 nm The binding 
energy of Ca, Ρ and Ο in the coating on the composites surface was similar to the original HA 
in the composites In conclusion, the structure of the inorganic- organic and 
inorgamc-orgamc/inorganic composites was comparable with natural bone, which can make 
them more bioactive and bone biocompatible Also the RF magnetron sputtering deposition 
and water steam heat treatment method can be applied for the modification of other polymer 
and polymer composite surfaces 
Final remarks 
On basis of the obtained results we could conclude that magnetron sputtering is an excellent 
method for forming DCPP coatings onto metallic and polymeric substrates Using rf 
magnetron sputtering it is possible to deposit thin, dense, homogenous and well adhering CaP 
coatings All the as-sputtered coatings are amorphous and dissolve in simulated body fluid 
(SBF) Heat treatment below 650° C did not result in crystallization of amorphous DCPP 
coatings Under these conditions only the amorphous HA coating transformed into a 
crystalline apatite structure However, after heat treatment at temperature of 650° C, the 
amorphous DCPP coating changed into a crystalline ß-Ca2P207 structure All heat-treated 
sputter coatings were observed to be stable and no dissolution or precipitate deposition was 
seen after incubation in SBF On the other hand, a disadvantage of IR-radiation is an increase 
in the thickness of the Ti02 layer Nevertheless, this increase is not considered to be 
unfavorable for the long-term bone response (chapter 2 and 3) During the production of 
mixtures of hydroxylapatite and calcium pyrophosphate coatings, we found that the Ca/P 
ratio of the coatings varied from 0 55 to 2 0 Further, different phase compositions or 
mixtures of apatite, beta-pyrophosphate and beta-tncalciumphosphate structures were formed 
The phase compositions of the sputtered coatings are determined not only by the discharge 
power ratio of the hydroxylapatite and dicalcium pyrophosphate target, but also by the 
annealing temperature 
In this thesis, different crystallization procedures were used to crystallize the amorphous 
coatings The most used heat treatment is heating in a furnace at high temperature (e g , above 
600oC) in air This heat treatment can reduce the adhesive strength of a sputtered CaP coating 
to the underlying substrate surface and can even result in the buckling of the coating at the 
surface Also it is known, that with increasing temperature of the heat treatment, the purity of 
the HA phase in the coating decreases We decided to heat the coatings either with infrared at 
high temperature (500-700oC) for a very short time (30 seconds) or water steam at a lower 
temperature for a long time (140oC) Infrared heat treatment induced no changes in the 
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coating morphology, while steam heating resulted in the deposition of a CaP precipitate on 
the coated surface Further, after incubation in SBF these heat-treated coatings appeared to be 
present, resulting in the formation of a carbonated apatite precipitate on both infrared and 
steam heated HA coating surface, while on the DCPP coatings a TCP phase was formed 
(chapter 4) 
The growth and differentiation of bone-like cells on magnetron sputtered DCPP and HA 
coatings were compared On the infrared heated HA coatings, the cells proliferated well and 
formed a multilayer of cells with extensive collagen fiber formation and surface 
mineralization in the form of globular accretions, while on the steam treated HA surfaces, the 
cell proliferation was combined with the deposition of very fine mineralization particles The 
same was observed for the steam heated DCPP coatings, although the number of cells 
appeared to be somewhat less On the infrared heated DCPP surface a multilayer of cells was 
observed, but the deposition of calcified globuli was very limited (chapter 4 and 5) 
In addition, an in vivo expenment of DCPP coatings showed a biocompatible tissue behavior 
charactenzed by the formation of a thin fibrous tissue capsule and the absence of an 
inflammatory response Further, infrared heat-treated DCPP coatings revealed a gradual 
compositional change into apatite and TCP Of course, the conclusive beneficial effect of 
DCPP coatings has to be proven in a bone implantation study 
Future research 
The results of this study lead to the following recommendation for future research 
First, our knowledge about how bone formation on calcium phosphate ceramics occurs, is 
still at best rudimentary This lack of knowledge hampers the safe application and further 
development of biomatenals eliciting predictable and controlled bone responses as required 
by their application Therefore, the mechanism of the underlying process and the exact 
benefit of DCPP coatings have to be proven Further, care has to be taken of the fact that the 
precise structure of synthetic CaP compounds can differ considerably of the natural material 
Starting material and processing route are very important parameters for the finally prepared 
product How this interferes with the aimed tissue response is yet unclear Therefore, in depth 
physicochemical analysis has to be focused at the coating/biological tissue interface In this 
way, information will be provided about the mechanism involved in the dissolution of 
calcium ions from the coating and the relation of this Ca"+ dissolution to apatite and 
tncalcium phosphate deposition and extracellular matrix maturation For example, studies can 
be performed to examine the influence of coating parameters on the behavior of extracellular 
proteins and the subsequent bone formation process 
Secondly, heat treatment in steam is introduced as a suitable method to improve the 
crystallinity of the as-deposited coatings This application increases the heating time and can 
have a great influence on the morphology and interfacial properties of the coating surface 
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However, more insight of steam heating has to be obtained on the final changes of the 
calcium phosphate coatings during this treatment. These experiments have not only to 
involve the structural changes of the coating. Also, final adhesion strength of the coating to 
underlying substrate needs more attention, because this can seriously hamper the clinical 






Wanneer we de chemische samenstelling, structuur en de biologische eigenschappen van 
calciumfosfaat keramiek in ogenschouw nemen, blijken deze materialen uitstekend 
toepasbaar voor de vervaardiging van orthopedische en tandheelkundige implantaten, 
gebruikt bij het herstel van botdefecten en ter vervanging van verloren tanden. 
Calciumfosfaat (CaP) keramiek veroorzaakt een snelle fixatie en sterkere binding tussen 
implantaat en het bot en verhoogt een gelijkmatige bot ingroei. Helaas zijn de mechanische 
eigenschappen van calciumfosfaat keramiek slecht. Het keramiek is vrij bros en 
breukgevoelig, dit beperkt de toepasbaarheid van dit materiaal in belaste situaties. Daarom 
richt ons onderzoek zich op de ontwikkeling van CaP coatings aangebracht op sterke metalen 
substraten. In onze studies gebruiken wij titaan substraten vanwege de goede biocompatibele 
en mechanische eigenschappen van dit materiaal. Calciumfosfaat keramieken zijn Ca en Ρ 
bevattende materialen, die kunnen verschillen in chemische samenstelling, structuur, 
kristalliniteit en morfologie. Verder is het mogelijk om onder bepaalde fysisch-chemische en 
biologische omstandigheden een overgang te krijgen van de ene in een ander calciumfosfaat 
fase. Ook beïnvloedt de productie methode de eigenschappen van het materiaal. Over het 
algemeen zijn CaP materialen biocompatibel en betrokken bij de botvorming, een 
uitzondering hierop is monocalciumfosfaat (MCP; Ca (H2P04)2), dit materiaal is te zuur om 
celgroei te bevorderen. 
Hydroxyapatiet (HA) is het hoofdbestanddeel van bot. Andere CaP keramieken, zoals CHA 
(carbonaat hydroxyapatiet), DCPP (dicalcium pyrofosfaat) and OCP (octa calcium fosfaat) 
spelen echter ook een rol in het biologische proces met betrekking tot de bot vorming. Tijdens 
de vorming van HA, vinden degradatie en transformatie van verschillende CaP fases plaats. 
Om dit proces beter te begrijpen, onderzochten wij de rol van DCPP en HA. Uit de literatuur 
blijkt dat een hittebehandeling achteraf de fysisch-chemische eigenschappen van CaP 
keramiek sterk kunnen beïnvloeden. Verder heeft deze nabehandeling ook effect op de 
uiteindelijke reactie van dit materiaal in een biologische omgeving. In onze studies maken wij 
gebruik van verschillende hittebehandelingen achteraf om de RF magnetron gesputterde CaP 
coatings met verschillende eigenschappen te verkrijgen. 
In hoofdstuk 1 geven we een algemeen overzicht met betrekking tot de achtergrond van bot, 
calciumfosfaat keramiek, coatings, hitte behandelingen, morfologie en biocompatibiliteit. 
In hoofdstuk 2 werd gebruik gemaakt van RF magnetron sputter techniek om calcium 
pyrofosfaat en hydroxylapatiet coatings aan te brengen op metalen substraten. X-ray 
diffractie (XRD) liet zien dat infrarood (IR) hittebehandeling de amorfe structuur van 
geputterde coatings veranderde in een kristallijne structuur. De temerpatuur van de 
kristallisatie van amorfe coatings is lager voor hydroxylapatiet coatings (550oC), in 
vergelijking met de calcium pyrofaat coatings (650oC). Scanning elektronen microscopie 
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(SEM) en energie dispersieve spectrometrie (EDS) toonden aan dat de gesputterde coatings 
een uniforme structuur hadden met een Ca/P verhouding van 0 55-2 0 Het oplosgedrag van 
deze calciumfosfaat coatings werd bepaald in een zoutoplossing gelijkend op weefselvocht 
(simulated body fluid (SBF)) Alle amorfe coatings waren instabiel en losten gedeeltelijk op 
na 4 weken incubatie Daarentegen bleek dat alle hittebehandelde coatings stabiel waren 
onder deze testcondities Op basis van deze bevindingen, werd geconcludeerd dat RF 
magnetron sputteren van calcium pyrofosfaat coating een veelbelovende techniek is om 
biocompatibele coatings te vervaardigen 
In hoofdstuk 3 werden mengsels van hydroxylapatiet en calcium pyrofosfaat coatings op 
titanium substraten onderzocht De CaP coatings werden geproduceerd met verschillende 
sputtercondities en hierbij werd het sputtervermogen gevarieerd Alle gesputterde coatings 
waren amorf Na een IR hitte behandeling veranderde de amorfe structuur in een kristallijne 
structuur De kristalhsatie temperatuur van amorfe pyrofosfaat coatings was hoger in 
vergelijking met amorfe HA coatings De verkregen coatings hadden een Ca/P ratio van 
0 55-2 10 en heten verschillende fases zien, bestaande uit mengsels van apatiet, 
beta-pyrofosfaat en beta-tncalciumfosfaat Hieruit bleek dat de fase samenstelling niet alleen 
bepaald werd door het sputtervermogen, maar ook door de hitte-behandeling 
In hoofdstuk 4 werden verschillende hitte nabehandelingen van DCPP en HA coatings met 
elkaar vergeleken De onderzochte coatings waren zoals gesputterd (amorfe HA coating, 
Α-HA, amorfe dicalcium pyrofosfaat coating, A-DCPP), IR hitte-behanded bij 550oC (I-HA) 
of bij 650oC (I-DCPP), en stoom behandeld bij 140oC (S-HA and S-DCPP) De resultaten 
heten zien dat alle gesputterde coatings een amorfe structuur hadden en alle hitte-behandelde 
coatings een knstalhjne structuur Uit het oplosgedrag in SBF bleek dat de onverhitte 
coatings instabiel waren en bijna volledig oplosten na 4 weken incubatie Daarentegen bleven 
alle hitte-behandelde coatings in stand Infrarood onderzoek (FTIR) toonde de vorming van 
een carbonaatapatiet fase op de I-HA and S-HA coating oppervlak, terwijl op de I-DCPP en 
S-DCPP coatings een TCP fase was gevormd 
De Ca/P ratio van de Α-HA, I-HA, S-HA, A-DCPP, I-DCPP and S-DCPP coatings veranderde 
respectievelijk van 1 98-1 12, 2 01-1 76, 1 91-1 68, 0 76-1 23, 0 76-1 26 en 1 62-1 55 na 4 
weken incuberen in SBF 
De biocompatibihteit van de coatings werd met behulp van celkweek expenmenten bepaald 
Hieruit bleek dat de gesputterde coatings biocompatibel zijn Op basis van deze bevindingen 
werd geconcludeerd dat verschillende hitte-behandelingen de morfologie van gesputterde HA 
en DCPP coatings veranderde, waarbij een combinatie van kristalliniteit en specifieke fase 




Het doel van het onderzoek in hoofdstuk 5 was om de osteogene eigenschappen van RF 
magnetron gesputterde dicalcium pyrofosfaat (DCPP) en hydroxyapatiet (HA) coatings te 
evalueren Daarvoor werd het effect van DCPP en HA coatings bestudeerd, met betrekking 
tot de groei en differentiatie van osteoblast-achtige cellen Uit de resultaten bleek dat de 
osteoblast-achtige cellen niet groeien en differentieren op de amorfe coatings SEM het zien 
dat de amorfe coatings duidelijk oplosten De knstallijne DCPP en HA coatings heten een 
toename zien van de DNA en alkalische fosfatase activiteit van af dag 8 De osteocalcine 
expressie nam toe vanaf dag 16 SEM liet zien dat de groei en differentiatie van de cellen 
samenging met extensieve vorming van collagene fibers en minerahsatie Verder, lieten 
statische analyses zien dat de groei en differentiatie van de osteoblast-achtige cellen 
significant eerder begon op de knstallijne HA coatings dan op de knstallijne DCPP coatings 
Hieruit werd geconcludeerd dat osteoblast-achtige cellen groeien en differentieren op 
kristallijn magnetron gesputterde DCPP en HA coatings en dit resultaat rechtvaardigt verdere 
in vivo onderzoek naar de bot eigenschappen van deze coatings tijdens botgenezing 
In hoofdstuk 6 wordt een m vivo experiment beschreven, waann schijfjes met RF magnetron 
gesputterde hydroxyapatiet (HA) and calcium pyrofosfaat (DCPP) coatings onderhuids in de 
rug van geiten werden geïmplanteerd De laagdikte bedroeg 2 0 μιτι Alle gesputterde 
coatings werden IR hitte-behandeld, HA (550oC) en DCPP (650°C) De gecoate schijfjes 
werden ingebracht gedurende 2, 4, 8 and 12 weken SEM het zien dat de gesputterde HA 
coatings na 12 weken implantatie nog grotendeels aanwezig waren Verder werd met behulp 
van XRD aangetoond dat de coatings niet waren opgelost EDS metingen toonde aan dat de 
Ca/P ratio van de HA coatings niet veranderde na 12 weken implantatie Daarentegen 
transformeerde hitte-behandelde DCPP coatings in een apatiet- en een tncalciumfosfaat fase 
gedurende 12 weken implantatie Verder veranderde de Ca/P ratio van 0 8 naar 1 52 Uit de 
histologische waarnemingen bleek dat alle implantaten omgeven waren met een dun, dicht 
fibreus kapsel met af en toe de aanwezigheid van enkele ontstekings cellen Uit deze 
bevindingen kan geconcludeerd worden dat in vivo een 2 μπι dikke gesputterde IR 
hitte-behandelde HA en DCPP coating voldoende laagdikte heeft met betrekking tot oplos- en 
bioactieve eigenschappen 
In hoofdstuk 7 werden dunne gesputterde HA coatings op polyamide-6 (PA-6) en een nano 
HA/Polyamide-6 (NHA/PA-6) composiet aangebracht SEM onderzoek toonde aan dat de 
gesputterde coatings de polymeren homogeen bedekte Verder toonde XRD aan dat de 
gecoate laag een amorfe structuur had Met een stoom behandeling veranderde de amorfe 
structuur in een knstallijne HA structuur EDS het zien dat de verkregen coating een Ca/P 
ratio had van 1 64 
Hieruit werd geconcludeerd dat RF magnetron sputtenng een geschikte methode is om dunne 
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coatings op polymeren aan te brengen en een stoom hitte-behandeling een geschikte techniek 
is om amorf HA te kristalliseren. 
In hoofstuk 8 zijn de belangrijkste conclusies van dit proefschrift samengevat en werden 
suggesties gegeven voor verder onderzoek. 
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